<SEC-DOCUMENT>0001140361-25-037966.txt : 20251014
<SEC-HEADER>0001140361-25-037966.hdr.sgml : 20251014
<ACCEPTANCE-DATETIME>20251010182752
ACCESSION NUMBER:		0001140361-25-037966
CONFORMED SUBMISSION TYPE:	424B2
PUBLIC DOCUMENT COUNT:		4
FILED AS OF DATE:		20251014
DATE AS OF CHANGE:		20251010

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TORONTO DOMINION BANK
		CENTRAL INDEX KEY:			0000947263
		STANDARD INDUSTRIAL CLASSIFICATION:	COMMERCIAL BANKS, NEC [6029]
		ORGANIZATION NAME:           	02 Finance
		EIN:				135640479
		STATE OF INCORPORATION:			A6
		FISCAL YEAR END:			1031

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-283969
		FILM NUMBER:		251388930

	BUSINESS ADDRESS:	
		STREET 1:		66 WELLINGTON STREET WEST
		STREET 2:		12TH FLOOR, TD TOWER
		CITY:			TORONTO, ONTARIO
		STATE:			A6
		ZIP:			M5K 1A2
		BUSINESS PHONE:		416-944-6367

	MAIL ADDRESS:	
		STREET 1:		66 WELLINGTON STREET WEST
		STREET 2:		12TH FLOOR, TD TOWER
		CITY:			TORONTO, ONTARIO
		STATE:			A6
		ZIP:			M5K 1A2
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B2
<SEQUENCE>1
<FILENAME>ef20056889_424b2.htm
<DESCRIPTION>PRELIMINARY PRICING SUPPLEMENT
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 25.10.1.5333
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: Arial; font-size: 9pt; text-align: left; color: #000000;">
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div style="text-align: right; margin-bottom: 10pt; color: rgb(0, 0, 0); font-size: 8pt; font-weight: bold;">
        <table cellspacing="0" cellpadding="0" border="0" id="zc3d01e1eecd34a0facf0593bac57f265" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

            <tr>
              <td style="width: 50.00%;">
                <div>
                  <div style="text-align: left;"><img width="57" height="47" src="image0.jpg"></div>
                </div>
              </td>
              <td style="width: 50%; text-align: right; vertical-align: top;">
                <div style="color: rgb(0, 0, 0); font-size: 8pt; font-weight: bold;">Filed Pursuant to Rule 424(b)(2)</div>
                <div style="color: rgb(0, 0, 0); font-size: 8pt; font-weight: bold;">Registration Statement No. 333-283969</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="color: rgb(0, 0, 0); font-weight: 400;">
        <div style="text-align: justify; margin-bottom: 8pt; color: rgb(192, 80, 77); font-size: 8pt; font-weight: bold;">The information in this pricing supplement is not complete and may be changed. This pricing supplement is not an offer to sell nor
          does it seek an offer to buy these Notes in any state where the offer or sale is not permitted.</div>
      </div>
      <div style="text-align: justify; color: rgb(192, 80, 77); font-size: 8pt; font-weight: bold;">Subject to Completion, Dated October 10, 2025.</div>
      <table cellspacing="0" cellpadding="4" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z8ffc0abdd5024f5193d8f026ec528ecb">

          <tr>
            <td rowspan="1" style="width: 100%; vertical-align: top; background-color: rgb(0, 0, 0);"><br>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; font-size: 8.5pt;">Pricing Supplement dated, 2025 to the</div>
      <div style="text-align: justify; font-size: 8.5pt;">Product Supplement MLN-EI-1 dated February 26, 2025,</div>
      <div style="text-align: justify; font-size: 8.5pt;">Product Supplement MLN-ES-ETF-1 dated February 26, 2025</div>
      <div style="text-align: justify; font-size: 8.5pt;">Underlier Supplement dated February 26, 2025 and</div>
      <div style="text-align: justify; font-size: 8.5pt;">Prospectus dated February 26, 2025</div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z06269fcfadb34fbeb4565a60b052d03f">

          <tr>
            <td style="background-color: #F2F2F2; border-bottom: 4px solid #00B050; border-left: 4px solid #00B050; border-right: 4px solid #00B050; border-top: 4px solid #00B050; vertical-align: top; width: 100%;">
              <div style="text-align: center; color: rgb(0, 176, 80); font-size: 16pt;">The Toronto-Dominion Bank</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-size: 10pt;">$[&#9679;]</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-size: 10pt;">Leveraged Barrier Notes Linked to the Least Performing of the shares of the iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> MSCI EAFE ETF and the EURO</div>
              <div style="margin: 0px 0px 6pt; color: rgb(0, 0, 0); font-size: 10pt; text-align: center;"> STOXX 50<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index Due on or about October 21, 2030</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; margin-top: 6pt; margin-bottom: 3pt; font-size: 8pt;">The Toronto-Dominion Bank (&#8220;TD&#8221; or &#8220;we&#8221;) is offering the Leveraged Barrier Notes (the &#8220;Notes&#8221;) linked to the least performing of the shares of the iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup>
        MSCI EAFE ETF and the EURO STOXX 50<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index (each, a &#8220;Reference Asset&#8221; and together, the &#8220;Reference Assets&#8221;). We also refer to an exchange-traded fund as an &#8220;ETF&#8221;, a Reference Asset that is a share of an ETF as an &#8220;Equity Reference Asset&#8221;
        and a Reference Asset that is an index as an &#8220;Index Reference Asset&#8221;.</div>
      <div style="text-align: justify; margin-bottom: 3pt; font-size: 8pt;">The Notes provide 222.00% leveraged participation in the positive return of the Least Performing Reference Asset if the value of each Reference Asset increases from its Initial
        Value to its Final Value. The &#8220;Least Performing Reference Asset&#8221; is the Reference Asset with the lowest Percentage Change (the &#8220;Least Performing Percentage Change&#8221;). The &#8220;Percentage Change&#8221; for each Reference Asset is the quotient, expressed as a
        percentage, of (i) its Final Value <font style="font-style: italic;">minus</font> its Initial Value <font style="font-style: italic;">divided</font> by (ii) its Initial Value.</div>
      <div style="text-align: justify; margin-bottom: 3pt; font-size: 7.5pt;"><font style="font-size: 8pt;">Investors will receive their Principal Amount at maturity if the Final Value of any Reference Asset is less than or equal to its Initial Value but
          the Final Value of each Reference Asset is greater than or equal to its Barrier Value, which is equal to 70.00% of its Initial Value. If, however, the Final Value of any Reference Asset is less than its Barrier Value, investors will suffer a
          percentage loss on their initial investment that is equal to the Least Performing Percentage Change, and may lose their entire Principal Amount. Specifically, investors will lose 1% of the Principal Amount of the Notes for each 1% that the Final
          Value of the Least Performing Reference Asset is less than its Initial Value, and may lose the entire Principal Amount.</font><font style="font-weight: bold; font-style: italic;">&#160;</font><font style="font-size: 8pt; font-weight: bold; font-style: italic;">Any payment on the Notes is subject to our credit risk.</font></div>
      <div>
        <div>
          <table cellspacing="0" cellpadding="0" border="0" id="z8e18c1f1776f45a88a67fd221fd6df6a" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 1%; border-left: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);"><br>
                </td>
                <td style="width: 98%; border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
                  <div style="text-align: justify; margin-bottom: 3pt; font-size: 8pt; font-weight: bold;">Investors are exposed to the market risk of each Reference Asset on the Final Valuation Date and any decline in the value of one Reference Asset will
                    not be offset or mitigated by a lesser decline or potential increase in the value of any other Reference Asset. The Payment at Maturity will be greater than the Principal Amount only if the Final Value of each Reference Asset is greater
                    than its Initial Value. The Notes do not guarantee the return of the Principal Amount and investors may lose up to their entire investment in the Notes if the Final Value of any Reference Asset is less than its Barrier Value. Any
                    payment on the Notes is subject to our credit risk.</div>
                </td>
                <td style="width: 1%; border-top: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
                  <div>&#160;</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="margin: 2pt 0px; font-size: 8pt; text-align: justify;">The Notes are unsecured and are not savings accounts or insured deposits of a bank. The Notes are not insured or guaranteed by the Canada Deposit Insurance Corporation, the U.S.
        Federal Deposit Insurance Corporation or any other governmental agency or instrumentality of Canada or the United States. The Notes will not be listed or displayed on any securities exchange or electronic communications network.</div>
      <div style="text-align: justify; margin-bottom: 2pt; font-size: 8pt; font-weight: bold;">The Notes have complex features and investing in the Notes involves a number of risks. See &#8220;Additional Risk Factors&#8221; beginning on page P-6 of this pricing
        supplement, &#8220;Additional Risk Factors Specific to the Notes&#8221; beginning on page PS-7 of the product supplement MLN-EI-1 and the product supplement MLN-ES-ETF-1, each dated February 26, 2025 (together, the &#8220;product supplements&#8221;) and &#8220;Risk Factors&#8221; on
        page 1 of the prospectus dated February 26, 2025 (the &#8220;prospectus&#8221;).</div>
      <div style="text-align: justify; margin-bottom: 2pt; font-size: 8pt; font-weight: bold;">Neither the Securities and Exchange Commission (the &#8220;SEC&#8221;) nor any state securities commission has approved or disapproved of these Notes or determined that this
        pricing supplement, the product supplements, the underlier supplement or the prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</div>
      <div style="text-align: justify; margin-bottom: 2pt; font-size: 8pt;">We will deliver the Notes in book-entry only form through the facilities of The Depository Trust Company on the Issue Date against payment in immediately available funds.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-size: 8pt;">The estimated value of your Notes <font style="font-size: 7.5pt;">at the time the terms of your Notes are set</font> on the Pricing Date is expected to be between $930.00 and
        $965.00 per Note, as discussed further under &#8220;Additional Risk Factors &#8212; Risks Relating to Estimated Value and Liquidity&#8221; beginning on page P-9 and &#8220;Additional Information Regarding the Estimated Value of the Notes&#8221; on page P-23 of this pricing
        supplement. The estimated value is expected to be less than the public offering price of the Notes.</div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z135b63bfbf4b42698ff0cbc1e9556974">

          <tr>
            <td style="width: 18.64%; vertical-align: top; border-bottom: #D9D9D9 1px solid;"><br>
            </td>
            <td style="width: 27.12%; vertical-align: top; border-bottom: #D9D9D9 1px solid;">
              <div style="text-align: justify; margin-bottom: 3pt; font-size: 8pt; font-weight: bold;">Public Offering Price<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">1</sup></div>
            </td>
            <td style="width: 27.12%; vertical-align: top; border-bottom: #D9D9D9 1px solid;">
              <div style="text-align: justify; margin-bottom: 3pt; font-size: 8pt; font-weight: bold;">Underwriting Discount<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">1 2</sup></div>
            </td>
            <td style="width: 27.12%; vertical-align: top; border-bottom: #D9D9D9 1px solid;">
              <div style="text-align: justify; margin-bottom: 3pt; font-size: 8pt; font-weight: bold;">Proceeds to TD<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">2</sup></div>
            </td>
          </tr>
          <tr>
            <td style="width: 18.64%; vertical-align: top; border-top: #D9D9D9 1px solid; border-bottom: #D9D9D9 1px solid;">
              <div style="text-align: justify; margin-bottom: 3pt; color: rgb(0, 0, 0); font-size: 8pt;">Per Note</div>
            </td>
            <td style="width: 27.12%; vertical-align: top; border-top: #D9D9D9 1px solid; border-bottom: #D9D9D9 1px solid;">
              <div style="text-align: justify; margin-bottom: 3pt; color: rgb(0, 0, 0); font-size: 8pt;">$1,000.00</div>
            </td>
            <td style="width: 27.12%; vertical-align: top; border-top: #D9D9D9 1px solid; border-bottom: #D9D9D9 1px solid;">
              <div style="text-align: justify; margin-bottom: 3pt; color: rgb(0, 0, 0); font-size: 8pt;">Up to $6.00</div>
            </td>
            <td style="width: 27.12%; vertical-align: top; border-top: #D9D9D9 1px solid; border-bottom: #D9D9D9 1px solid;">
              <div style="text-align: justify; margin-bottom: 3pt; color: rgb(0, 0, 0); font-size: 8pt;">At least $994.00</div>
            </td>
          </tr>
          <tr>
            <td style="width: 18.64%; vertical-align: top; border-top: #D9D9D9 1px solid; border-bottom: #D9D9D9 1px solid;">
              <div style="text-align: justify; margin-bottom: 3pt; color: rgb(0, 0, 0); font-size: 8pt;">Total</div>
            </td>
            <td style="width: 27.12%; vertical-align: top; border-top: #D9D9D9 1px solid; border-bottom: #D9D9D9 1px solid;">
              <div style="text-align: justify; margin-bottom: 3pt; color: rgb(0, 0, 0); font-size: 8pt;">$</div>
            </td>
            <td style="width: 27.12%; vertical-align: top; border-top: #D9D9D9 1px solid; border-bottom: #D9D9D9 1px solid;">
              <div style="text-align: justify; margin-bottom: 3pt; color: rgb(0, 0, 0); font-size: 8pt;">$</div>
            </td>
            <td style="width: 27.12%; vertical-align: top; border-top: #D9D9D9 1px solid; border-bottom: #D9D9D9 1px solid;">
              <div style="text-align: justify; margin-bottom: 3pt; color: rgb(0, 0, 0); font-size: 8pt;">$</div>
            </td>
          </tr>

      </table>
      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zc3c1af13b4d04e78a09a380ef852e4be" style="font-family: Arial; font-size: 9pt; width: 100%;">

            <tr style="vertical-align: top;">
              <td style="text-align: right; vertical-align: top; width: 9pt;">
                <div style="text-align: justify; text-indent: -9pt; margin-left: 9pt; margin-top: 3pt; font-size: 7.5pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">1</sup></div>
              </td>
              <td style="text-align: left; vertical-align: top; width: auto;">
                <div style="text-align: justify; margin-top: 3pt; font-size: 7.5pt;">Certain dealers who purchase the Notes for sale to certain fee-based advisory accounts may forgo some or all of their selling concessions, fees or commissions. The public
                  offering price for investors purchasing the Notes in these accounts may be as low as $994.00 (99.40%) per Note.</div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="ze678beb135fc419b8840a6993fcb95ac" style="font-family: Arial; font-size: 9pt; width: 100%;">

            <tr style="vertical-align: top;">
              <td style="text-align: right; vertical-align: top; width: 9pt;">
                <div style="text-align: justify; text-indent: -9pt; margin-left: 9pt; margin-top: 3pt; font-size: 7.5pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">2</sup></div>
              </td>
              <td style="text-align: left; vertical-align: top; width: auto;">
                <div style="text-align: justify; margin-top: 3pt; font-size: 7.5pt;">TD Securities (USA) LLC (&#8220;TDS&#8221;) will receive a commission of up to $6.00 (0.60%) per Note and may use all or a portion of that commission to allow selling concessions to
                  other dealers in connection with the distribution of the Notes. Such other dealers may resell the Notes to other securities dealers at the Principal Amount less a concession not in excess of $6.00 per Note. The total &#8220;Underwriting
                  Discount&#8221; and &#8220;Proceeds to TD&#8221; to be specified above will reflect the aggregate of the underwriting discount at the time TD established any hedge positions on or prior to the Pricing Date, which may be variable and fluctuate depending on
                  market conditions at such times. TD will reimburse TDS for certain expenses in connection with its role in the offer and sale of the Notes, and TD will pay TDS a fee in connection with its role in the offer and sale of the Notes. See
                  &#8220;Supplemental Plan of Distribution (Conflicts of Interest)&#8221; herein.</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="text-align: justify; font-size: 8pt;">The public offering price, underwriting discount and proceeds to TD listed above relate to the Notes we issue initially. We may decide to sell additional Notes after the date of the final pricing
        supplement, at public offering prices and with underwriting discounts and proceeds to TD that differ from the amounts set forth above. The return (whether positive or negative) on your investment in the Notes will depend in part on the public
        offering price you pay for such Notes.</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div class="BRPFPageFooter" style="width: 100%;">
          <div>
            <div>
              <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

                  <tr>
                    <td style="width: 50.00%;">
                      <div style="font-size: 8pt; text-align: left;">TD SECURITIES (USA) LLC</div>
                    </td>
                    <td style="width: 50.00%;">
                      <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">1</font></div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z6482adc3c3274e31b34436295d34f4f1">

          <tr>
            <td style="width: 100%; vertical-align: middle;">
              <div style="text-align: right; color: rgb(0, 0, 0); font-size: 8pt; font-weight: bold;">&#160;Leveraged Barrier Notes Linked to the Least Performing of the shares of</div>
              <div style="text-align: right; color: rgb(0, 0, 0); font-size: 8pt; font-weight: bold;">&#160;the iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> MSCI EAFE ETF and the EURO STOXX 50<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index</div>
              <div style="margin: 0px 0px 10pt; color: rgb(0, 0, 0); font-size: 8pt; font-weight: bold; text-align: right;">Due on or about October 21, 2030</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="4" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td rowspan="1" style="width: 100%; vertical-align: top; background-color: rgb(0, 0, 0);"><br>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; margin-top: 18pt; margin-bottom: 6pt; color: rgb(0, 176, 80); font-size: 16pt;">Summary</div>
      <div style="text-align: justify; margin-bottom: 6pt;">The information in this &#8220;Summary&#8221; section is qualified by the more detailed information set forth in this pricing supplement, the product supplements, the underlier supplement and the prospectus.</div>
      <table cellspacing="0" cellpadding="4" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z3f113ae07c844977aa8ef65c307c4b15">

          <tr>
            <td style="width: 22%; vertical-align: top; border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Issuer:</div>
            </td>
            <td style="width: 78%; vertical-align: top; border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt;">TD</div>
            </td>
          </tr>
          <tr>
            <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Issue:</div>
            </td>
            <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt;">Senior Debt Securities, Series H</div>
            </td>
          </tr>
          <tr>
            <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Type of Note:</div>
            </td>
            <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt;">Leveraged Barrier Notes</div>
            </td>
          </tr>
          <tr>
            <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Term:</div>
            </td>
            <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt;">Approximately 5 years</div>
            </td>
          </tr>
          <tr>
            <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Reference Assets:</div>
            </td>
            <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt;">The shares of the iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> MSCI EAFE ETF (Bloomberg ticker: EFA UP, &#8220;EFA&#8221;) and the EURO STOXX 50<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index (Bloomberg ticker: SX5E, &#8220;SX5E&#8221;). We also refer to EFA as an
                &#8220;Equity Reference Asset&#8221; and SX5E as an &#8220;Index Reference Asset&#8221;.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">CUSIP / ISIN:</div>
            </td>
            <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt;">89115HXP7 / US89115HXP71</div>
            </td>
          </tr>
          <tr>
            <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Agent:</div>
            </td>
            <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt;">TDS</div>
            </td>
          </tr>
          <tr>
            <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Currency:</div>
            </td>
            <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt;">U.S. Dollars</div>
            </td>
          </tr>
          <tr>
            <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Minimum Investment:</div>
            </td>
            <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt;">$1,000 and minimum denominations of $1,000 in excess thereof</div>
            </td>
          </tr>
          <tr>
            <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Principal Amount:</div>
            </td>
            <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt;">$1,000 per Note</div>
            </td>
          </tr>
          <tr>
            <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Pricing Date:</div>
            </td>
            <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify;">October 16, 2025</div>
            </td>
          </tr>
          <tr>
            <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Issue Date:</div>
            </td>
            <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">October 21, 2025, which is the third DTC settlement day following the Pricing Date. Under Rule 15c6-1 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), trades in the
                secondary market generally are required to settle in one DTC settlement day (&#8220;T+1&#8221;), unless the parties to a trade expressly agree otherwise. Accordingly, purchasers who wish to trade the Notes in the secondary market on any date prior to
                one DTC settlement day before delivery of the Notes will be required, by virtue of the fact that each Note initially will settle in three DTC settlement days (&#8220;T+3&#8221;), to specify alternative settlement arrangements to prevent a failed
                settlement of the secondary market trade.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Final Valuation Date:</div>
            </td>
            <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify;">October 16, 2030, subject to postponement upon the occurrence of a market disruption event as described in the accompanying product supplements.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Maturity Date:</div>
            </td>
            <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 2pt;">October 21, 2030, subject to postponement upon the occurrence of a market disruption event as described in the accompanying product supplements.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="font-weight: bold; text-align: justify;">Payment at Maturity:</div>
            </td>
            <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt;">For each Note, we will pay you on the Maturity Date an amount in cash equal to:</div>
              <div style="text-align: justify; text-indent: -18pt; margin-left: 22.5pt; margin-bottom: 6pt;">&#8226;<font style="text-indent: 0px; font-size: 6pt;" class="TRGRRTFtoHTMLTab">&#160;&#160;&#160;&#160;</font>If the Final Value of each Reference Asset is greater than its
                Initial Value:</div>
              <div style="text-align: center;">$1,000 + ($1,000 &#215; Least Performing Percentage Change &#215; Leverage Factor).</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div class="BRPFPageFooter" style="width: 100%;">
          <div>
            <div>
              <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

                  <tr>
                    <td style="width: 50.00%;">
                      <div style="font-size: 8pt; text-align: left;">TD SECURITIES (USA) LLC</div>
                    </td>
                    <td style="width: 50.00%;">
                      <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">2</font></div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <table cellspacing="0" cellpadding="4" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td rowspan="1" style="width: 22%; vertical-align: top; border-bottom: 1px solid rgb(217, 217, 217);"><br>
            </td>
            <td rowspan="1" style="width: 78%; vertical-align: top; border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; text-indent: -18pt; margin-left: 22.5pt; margin-bottom: 6pt;">&#8226;<font style="text-indent: 0px; font-size: 6pt;" class="TRGRRTFtoHTMLTab">&#160;&#160;&#160;&#160;</font>If the Final Value of any Reference Asset is less than or
                equal to its Initial Value but the Final Value of each Reference Asset is greater than or equal to its Barrier Value:</div>
              <div style="text-align: center; margin-bottom: 6pt;">Principal Amount of $1,000.</div>
              <div style="text-align: justify; text-indent: -18pt; margin-left: 22.5pt; margin-bottom: 6pt;">&#8226;<font style="text-indent: 0px; font-size: 6pt;" class="TRGRRTFtoHTMLTab">&#160;&#160;&#160;&#160;</font>If the Final Value of any Reference Asset is less than its
                Barrier Value:</div>
              <div style="text-align: center; margin-bottom: 3pt;">$1,000 + ($1,000 &#215; Least Performing Percentage Change).</div>
              <div style="text-align: justify; margin-bottom: 6pt; font-style: italic; font-weight: bold;">If the Final Value of any Reference Asset is less than its Barrier Value, investors will suffer a percentage loss on their initial investment that is
                equal to the Least Performing Percentage Change. Specifically, investors will lose 1% of the Principal Amount of the Notes for each 1% that the Final Value of the Least Performing Reference Asset is less than its Initial Value, and may lose
                the entire Principal Amount. Any payment on the Notes is subject to our credit risk.</div>
              <div style="text-align: justify; margin-bottom: 6pt;">All amounts used in or resulting from any calculation relating to the Payment at Maturity will be rounded upward or downward, as appropriate, to the nearest cent.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Percentage Change:</div>
            </td>
            <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt;">For each Reference Asset, the Percentage Change is the quotient, expressed as a percentage, of the following formula:</div>
              <div style="text-align: center;"><u>Final Value &#8211; Initial Value</u></div>
              <div style="text-align: center; margin-bottom: 6pt;">Initial Value</div>
            </td>
          </tr>
          <tr>
            <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="margin-bottom: 6pt; font-weight: bold;">Initial Value:</div>
            </td>
            <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt;">With respect to EFA: $&#8226; (to be determined on the Pricing Date).</div>
              <div style="text-align: justify; margin-bottom: 6pt;">With respect to SX5E: &#8226; (to be determined on the Pricing Date).</div>
              <div style="text-align: justify; margin-bottom: 6pt;">The Initial Value of each Reference Asset equals its Closing Value on the Pricing Date, as determined by the Calculation Agent and, with respect to an Equity Reference Asset, subject to
                adjustment as described under &#8220;General Terms of the Notes &#8212; Anti-Dilution Adjustments&#8221; in the product supplement MLN-ES-ETF-1.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="margin-bottom: 6pt; font-weight: bold;">Closing Value:</div>
            </td>
            <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt;">With respect to an Index Reference Asset (or any &#8220;successor index&#8221; thereto, as defined in the product supplement MLN-EI-1) on any Trading Day, the Closing Value will be its closing value
                published by its sponsor (its &#8220;Index Sponsor&#8221;) as displayed on the relevant Bloomberg Professional<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> service (&#8220;Bloomberg&#8221;) page or any successor page or service.</div>
              <div style="text-align: justify; margin-bottom: 6pt;">With respect to an Equity Reference Asset, the Closing Value will be the closing sale price or last reported sale price (or, in the case of Nasdaq, the official closing price) for that
                Equity Reference Asset on a per-share or other unit basis, on any Trading Day for that Equity Reference Asset or, if such Equity Reference Asset is not quoted on any national securities exchange on that day, on any other market system or
                quotation system that is the primary market for the trading of such Equity Reference Asset.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="margin-bottom: 6pt; font-weight: bold;">Final Value:</div>
            </td>
            <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt;">For each Reference Asset, the Closing Value of such Reference Asset on its Final Valuation Date.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="margin-bottom: 6pt; font-weight: bold;">Barrier Value:</div>
            </td>
            <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="margin-bottom: 6pt;">With respect to EFA: $&#8226; (70.00% of its Initial Value, to be determined on the Pricing Date).</div>
              <div style="margin-bottom: 6pt;">With respect to SX5E: &#8226; (70.00% of its Initial Value, to be determined on the Pricing Date).</div>
              <div style="text-align: justify; margin-bottom: 6pt;">The Barrier Value for each Reference Asset is determined by the Calculation Agent and, with respect to an Equity Reference Asset, is subject to adjustment as described under &#8220;General Terms
                of the Notes &#8212; Anti-Dilution Adjustments&#8221; in the product supplement MLN-ES-ETF-1.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="font-weight: bold;">Least Performing Reference </div>
              <div style="font-weight: bold;">Asset:</div>
            </td>
            <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="margin-bottom: 6pt;">The Reference Asset with the lowest Percentage Change as compared to the Percentage Change of any other Reference Asset.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="font-weight: bold;">Least Performing Percentage</div>
              <div style="font-weight: bold;"> Change:</div>
            </td>
            <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="margin-bottom: 6pt;">The Percentage Change of the Least Performing Reference Asset.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="margin-bottom: 6pt; font-weight: bold;">Leverage Factor:</div>
            </td>
            <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="margin-bottom: 6pt;">222.00%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="margin: 3pt 0px 0px; font-weight: bold;">Monitoring Period:</div>
            </td>
            <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="margin: 3pt 0px 0px;">Final Valuation Date Monitoring</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div class="BRPFPageFooter" style="width: 100%;">
          <div>
            <div>
              <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

                  <tr>
                    <td style="width: 50.00%;">
                      <div style="font-size: 8pt; text-align: left;">TD SECURITIES (USA) LLC</div>
                    </td>
                    <td style="width: 50.00%;">
                      <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">3</font></div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <table cellspacing="0" cellpadding="4" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 22%; vertical-align: top; border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Trading Day:</div>
            </td>
            <td style="width: 78%; vertical-align: top; border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt;">With respect to an Equity Reference Asset, a day on which the principal trading market(s) for such Reference Asset is scheduled to be open for trading, as determined by the Calculation
                Agent.</div>
              <div style="text-align: justify; margin-bottom: 6pt;">With respect to an Index Reference Asset, a day on which (a) each related futures and options exchange is scheduled to be open for trading for its regular trading session and (b) the Index
                Sponsor of such Reference Asset is scheduled to publish the level of such Reference Asset, in each case as determined by the Calculation Agent.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Business Day:</div>
            </td>
            <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt;">Any day that is a Monday, Tuesday, Wednesday, Thursday or Friday that is neither a legal holiday nor a day on which banking institutions are authorized or required by law to close in New
                York City.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">U.S. Tax Treatment:</div>
            </td>
            <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify;">By purchasing the Notes, you agree, in the absence of a statutory or regulatory change or an administrative determination or judicial ruling to the contrary, to treat the Notes, for U.S. federal income tax
                purposes, as prepaid derivative contracts with respect to the Reference Assets. Based on certain factual representations received from us, our special U.S. tax counsel, Fried, Frank, Harris, Shriver &amp; Jacobson LLP, is of the opinion
                that it would be reasonable to treat the Notes in the manner described above. However, because there is no authority that specifically addresses the tax treatment of the Notes, it is possible that your Notes could alternatively be treated
                for tax purposes as a single contingent payment debt instrument, as a constructive ownership transaction under Section 1260 of the Code (as defined herein) or pursuant to some other characterization, such that the timing and character of
                your income from the Notes could differ materially and adversely from the treatment described above, as described further under &#8220;Material U.S. Federal Income Tax Consequences&#8221; herein and in the product supplements.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Canadian Tax Treatment:</div>
            </td>
            <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt;">Please see the discussion in the prospectus under &#8220;Tax Consequences &#8212; Canadian Taxation&#8221; and in the product supplements under &#8220;Supplemental Discussion of Canadian Tax Consequences&#8221;, which
                applies to the Notes. We will not pay any additional amounts as a result of any withholding required by reason of the rules governing hybrid mismatch arrangements contained in section 18.4 of the Canadian Tax Act (as defined in the
                prospectus).</div>
            </td>
          </tr>
          <tr>
            <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Calculation Agent:</div>
            </td>
            <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt;">TD</div>
            </td>
          </tr>
          <tr>
            <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Listing:</div>
            </td>
            <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt;">The Notes will not be listed or displayed on any securities exchange or electronic communications network.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Canadian Bail-in:</div>
            </td>
            <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt;">The Notes are not bail-inable debt securities (as defined in the prospectus) under the Canada Deposit Insurance Corporation Act.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Change in Law Event:</div>
            </td>
            <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">Applicable, as described in the applicable product supplement.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; font-style: italic;">The Pricing Date, the Issue Date, and all other dates listed above are subject to change. These dates will be set forth in the final pricing supplement that will be made available in connection
        with sales of the Notes.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <div>
            <div>
              <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

                  <tr>
                    <td style="width: 50.00%;">
                      <div style="font-size: 8pt; text-align: left;">TD SECURITIES (USA) LLC</div>
                    </td>
                    <td style="width: 50.00%;">
                      <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">4</font></div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-bottom: 12pt; color: rgb(0, 176, 80); font-size: 16pt;">Additional Terms of Your Notes</div>
      <div style="text-align: justify; margin-bottom: 6pt;">You should read this pricing supplement together with the prospectus, as supplemented by the product supplement MLN-EI-1 and the product supplement MLN-ES-ETF-1
          (together, the &#8220;product supplements&#8221;) and the underlier supplement (the &#8220;underlier supplement&#8221;), relating to our Senior Debt Securities, Series H, of which these Notes are a part. Capitalized terms used but not defined in this pricing
        supplement will have the meanings given to them in the applicable product supplement. In the event of any conflict the following hierarchy will govern: first, this pricing supplement; second, the applicable product supplement; third, the underlier
        supplement; and last, the prospectus. <font style="font-weight: bold; font-style: italic;">The Notes vary from the terms described in the product supplements in several important ways. You should read this pricing supplement carefully.</font></div>
      <div style="text-align: justify; margin-bottom: 6pt;">This pricing supplement, together with the documents listed below, contains the terms of the Notes and supersedes all prior or contemporaneous oral statements as well as any other written
        materials including preliminary or indicative pricing terms, correspondence, trade ideas, structures for implementation, sample structures, brochures or other educational materials of ours. You should carefully consider, among other things, the
        matters set forth in &#8220;Additional Risk Factors&#8221; herein, &#8220;Additional Risk Factors Specific to the Notes&#8221; in the product supplements and &#8220;Risk Factors&#8221; in the prospectus, as the Notes involve risks not associated with conventional debt securities. We
        urge you to consult your investment, legal, tax, accounting and other advisors concerning an investment in the Notes. You may access these documents on the SEC website at www.sec.gov as follows (or if that address has changed, by reviewing our
        filings for the relevant date on the SEC website):</div>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-bottom: 6pt;" class="DSPFListTable" id="z98d03eae20894db899b9c4306b3e92ee">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">&#9726;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Prospectus dated February 26, 2025:</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; text-indent: 36pt; margin-bottom: 6pt;"><a href="https://www.sec.gov/Archives/edgar/data/947263/000119312525036639/d931193d424b5.htm">http://www.sec.gov/Archives/edgar/data/947263/000119312525036639/d931193d424b5.htm</a></div>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-bottom: 6pt;" class="DSPFListTable" id="zf7b87210988f493fa890d6332d1725c3">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">&#9726;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Underlier Supplement dated February 26, 2025:</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; text-indent: 36pt; margin-bottom: 6pt;"><a href="https://www.sec.gov/Archives/edgar/data/947263/000114036125006121/ef20044458_424b3.htm">http://www.sec.gov/Archives/edgar/data/947263/000114036125006121/ef20044458_424b3.htm</a></div>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-bottom: 6pt;" class="DSPFListTable" id="zb1466eb4dd03435d8c8542d5eac45910">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">&#9726;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Product Supplement MLN-EI-1 dated February 26, 2025:</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; text-indent: 36pt; margin-bottom: 6pt;"><a href="https://www.sec.gov/Archives/edgar/data/947263/000114036125006123/ef20044459_424b3.htm">http://www.sec.gov/Archives/edgar/data/947263/000114036125006123/ef20044459_424b3.htm</a></div>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-bottom: 6pt;" class="DSPFListTable" id="zcddea874ef774f20822b14154ff8ea27">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">&#9726;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Product Supplement MLN-ES-ETF-1 dated February 26, 2025:</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; text-indent: 36pt; margin-bottom: 6pt;"><a href="https://www.sec.gov/Archives/edgar/data/947263/000114036125006132/ef20044456_424b3.htm">http://www.sec.gov/Archives/edgar/data/947263/000114036125006132/ef20044456_424b3.htm</a></div>
      <div style="text-align: justify; margin-bottom: 6pt;">Our Central Index Key, or CIK, on the SEC website is 0000947263. As used in this pricing supplement, the &#8220;Bank,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; or &#8220;our&#8221; refers to The Toronto-Dominion Bank and its subsidiaries.</div>
      <div style="text-align: justify;">We reserve the right to change the terms of, or reject any offer to purchase, the Notes prior to their issuance. In the event of any changes to the terms of the Notes, we will notify you and you will be asked to
        accept such changes in connection with your purchase. You may also choose to reject such changes, in which case we may reject your offer to purchase.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <div>
            <div>
              <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

                  <tr>
                    <td style="width: 50.00%;">
                      <div style="font-size: 8pt; text-align: left;">TD SECURITIES (USA) LLC</div>
                    </td>
                    <td style="width: 50.00%;">
                      <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">5</font></div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-bottom: 12pt; color: rgb(0, 176, 80); font-size: 16pt;">Additional Risk Factors</div>
      <div style="text-align: justify; margin-top: 6pt;">The Notes involve risks not associated with an investment in conventional debt securities. This section describes the most significant risks relating to the terms of the Notes. For additional
        information as to these and other risks, please see &#8220;Additional Risk Factors Specific to the Notes&#8221; in the product supplements and &#8220;Risk Factors&#8221; in the prospectus.</div>
      <div style="text-align: justify; margin-top: 6pt;">Investors should consult their investment, legal, tax, accounting and other advisors as to the risks entailed by an investment in the Notes and the suitability of the Notes in light of their
        particular circumstances.</div>
      <div style="text-align: center; margin-top: 12pt; margin-bottom: 12pt; font-style: italic; font-weight: bold;">Risks Relating to Return Characteristics</div>
      <div style="margin-top: 6pt; font-weight: bold;">Your Investment in the Notes May Result in a Loss.</div>
      <div style="text-align: justify; margin-top: 6pt;">The Notes do not guarantee the return of the Principal Amount and investors may lose up to their entire investment in the Notes. Specifically, if the Final Value of any Reference Asset is less than
        its Barrier Value, investors will lose 1% of the Principal Amount of the Notes for each 1% that the Final Value of the Least Performing Reference Asset is less than its Initial Value, and may lose the entire Principal Amount.</div>
      <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">The Notes Do Not Pay Interest and Your Return May Be Less Than the Return on a Conventional Debt Security of Comparable Maturity.</div>
      <div style="text-align: justify; margin-top: 6pt;">There will be no periodic interest payments on the Notes as there would be on a conventional fixed-rate or floating-rate debt security having a comparable maturity. The return that you will receive
        on your Notes, which could be negative, may be less than the return you could earn on other investments. Even if your return on the Notes is positive, your return may be less than the return you would earn if you bought a conventional
        interest-bearing senior debt security of TD of comparable maturity. Your investment may not reflect the full opportunity cost to you when you take into account factors that affect the time value of money.</div>
      <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">The Payment at Maturity Is Not Linked to the Value of Any Reference Asset at Any Time Other than as of the Final Valuation Date.</div>
      <div style="text-align: justify; margin-top: 6pt;">The Final Value of each Reference Asset will be based on its Closing Value on the Final Valuation Date (as may be adjusted with respect to the Equity Reference Asset as described in the product
        supplement MLN-ES-ETF-1). Therefore, if the Closing Value of any Reference Asset dropped precipitously on the Final Valuation Date, the Payment at Maturity for your Notes may be significantly less than it would have been had the Payment at Maturity
        been linked to the Closing Values of the Reference Assets prior to such drop. Although the actual Closing Values of the Reference Assets on the Maturity Date or at other times during the term of your Notes may be higher than their Closing Values on
        the Final Valuation Date, your return is based only on the Closing Value of the Least Performing Reference Asset on the Final Valuation Date.</div>
      <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">You Will Have No Rights to Receive Any Shares of Any Equity Reference Asset and You Will Not Be Entitled to Any Dividends or Other Distributions on Any Equity Reference Asset.</div>
      <div style="text-align: justify; margin-top: 6pt;">The Notes are our debt securities. They are not equity instruments, shares of stock, or securities of any other issuer. Investing in the Notes will not make you a holder of shares of any Equity
        Reference Asset. You will not have any voting rights, any rights to receive dividends or other distributions, or any rights against the issuer of any Equity Reference Asset. As a result, the return on your Notes may not reflect the return you would
        realize if you actually owned shares of any Reference Asset and received any dividends paid or other distributions made in connection with them. Your Notes will be paid in cash and you have no right to receive delivery of shares of any Reference
        Asset.</div>
      <div style="text-align: center; margin-top: 12pt; margin-bottom: 12pt; font-style: italic; font-weight: bold;">Risks Relating to Characteristics of the Reference Assets</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">There Are Market Risks Associated With Each Reference Asset.</div>
      <div style="text-align: justify;">The value of each Reference Asset can rise or fall sharply due to factors specific to such Reference Asset, its Reference Asset Constituents and their issuers (the &#8220;Reference Asset Constituent Issuers&#8221;) and, with
        respect to an Equity Reference Asset, its investment adviser (its &#8220;Investment Adviser&#8221;), such as stock price volatility, earnings, financial conditions, corporate, industry and regulatory developments, management changes and decisions and other
        events, as well as general market factors, such as general stock market volatility and levels, interest rates and economic and political conditions. You, as an investor in the Notes, should make your own investigation into the Reference Assets for
        your Notes. For additional information, see &#8220;Information Regarding the Reference Assets&#8221; in this pricing supplement. <font style="font-weight: bold;">We urge you to review financial and other information filed periodically by any Investment
          Adviser with the SEC.</font></div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <div>
            <div>
              <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

                  <tr>
                    <td style="width: 50.00%;">
                      <div style="font-size: 8pt; text-align: left;">TD SECURITIES (USA) LLC</div>
                    </td>
                    <td style="width: 50.00%;">
                      <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">6</font></div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Investors Are Exposed to the Market Risk of Each Reference Asset on the Final Valuation Date.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">Your return on the Notes is not linked to a basket consisting of the Reference Assets. Rather, it will be contingent upon the performance of each Reference Asset. Unlike an instrument with a
        return linked to a basket of indices, common stocks or other underlying securities, in which risk is mitigated and diversified among all of the components of the basket, you will be exposed equally to the risks related to each Reference Asset on
        the Final Valuation Date. Poor performance by any Reference Asset over the term of the Notes will negatively affect your return and will not be offset or mitigated by a positive performance by any other Reference Asset. For instance, if the Final
        Value of any Reference Asset is less than its Barrier Value on its Final Valuation Date, you will receive a negative return equal to the Least Performing Percentage Change, even if the Percentage Change of another Reference Asset is positive or has
        not declined as much. Accordingly, your investment is subject to the market risk of each Reference Asset.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Because the Notes Are Linked to the Least Performing Reference Asset, You Are Exposed to a Greater Risk of Losing a Significant Portion or All of Your Initial Investment at
        Maturity Than if the Notes Were Linked to a Single Reference Asset.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">The risk that you will lose a significant portion or all of your initial investment in the Notes is greater if you invest in the Notes than the risk of investing in substantially similar
        securities that are linked to the performance of only one Reference Asset. With more Reference Assets, it is more likely that the Final Value of any Reference Asset will be less than its Barrier Value on the Final Valuation Date than if the Notes
        were linked to a single Reference Asset.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">In addition, the lower the correlation is between the performance of a pair of Reference Assets, the more likely it is that one of the Reference Assets will decline in value to a Final Value that
        is less than its Barrier Value on the Final Valuation Date. Although the correlation of the Reference Assets&#8217; performance may change over the term of the Notes, the economic terms of the Notes, including the Leverage Factor and Barrier Values are
        determined, in part, based on the correlation of the Reference Assets&#8217; performance calculated using our internal models at the time when the terms of the Notes are finalized. All things being equal, a higher Leverage Factor and lower Barrier Values
        are generally associated with lower correlation of the Reference Assets. Therefore, if the performance of a pair of Reference Assets is not correlated to each other or is negatively correlated, the risk that the Final Value of any Reference Asset
        will be less than its Barrier Value will occur is even greater despite a lower Barrier Value. Therefore, it is more likely that you will lose a significant portion or all of your initial investment at maturity.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">We Have No Affiliation With Any Index Sponsor or Investment Adviser and Will Not Be Responsible for Any Actions Taken by Any Index Sponsor or Investment Adviser.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">No Index Sponsor or Investment Adviser is an affiliate of ours and no such entity will be involved in any offering of the Notes in any way. Consequently, we have no control of any actions of any
        Index Sponsor or Investment Adviser, including any actions of the type that could adversely affect the value of the applicable Reference Asset or any amounts payable on the Notes. No Index Sponsor or Investment Adviser has any obligation of any
        sort with respect to the Notes. Thus, no Index Sponsor or Investment Adviser has any obligation to take your interests into consideration for any reason, including in taking any actions that might affect the value of the Notes. None of our proceeds
        from any issuance of the Notes will be delivered to any Index Sponsor or Investment Adviser, except to the extent that we are required to pay an Index Sponsor licensing fees with respect to the applicable Reference Asset.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">The Value of an Equity Reference Asset May Not Completely Track Its NAV.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">The net asset value (&#8220;NAV&#8221;) of an ETF, including an Equity Reference Asset, may fluctuate with changes in the market value of its Reference Asset Constituents. The market values of an ETF may
        fluctuate in accordance with changes in NAV and supply and demand on the applicable stock exchange(s). Furthermore, the Reference Asset Constituents may be unavailable in the secondary market during periods of market volatility, which may make it
        difficult for market participants to accurately calculate the intraday NAV per share of the applicable Equity Reference Asset and may adversely affect the liquidity and prices of such Equity Reference Asset, perhaps significantly. For any of these
        reasons, the market value of an Equity Reference Asset may differ from its NAV per share and may trade at, above or below its NAV per share.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Adjustments to an Equity Reference Asset Could Adversely Affect the Notes.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">The Investment Adviser (as specified under &#8220;Information Regarding the Reference Assets&#8221;) for each Equity Reference Asset is responsible for calculating and maintaining the applicable Equity
        Reference Asset. An Investment Adviser can add, delete or substitute the Reference Asset Constituents for its Equity Reference Asset. An Investment Adviser may make other methodological changes to its Equity Reference Asset that could change the
        value of such Equity Reference Asset at any time. If one or more of these events occurs, the Closing Value of such Equity Reference Asset may be adjusted to reflect such event or events, which could adversely affect whether and the extent to which
        any amounts may be payable on the Notes and/or the market value of the Notes.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Changes that Affect the Target Index of the iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> MSCI EAFE ETF Will Affect the Market Value of, and Return on, the Notes.</div>
      <div style="text-align: justify;">The iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> MSCI EAFE ETF is an ETF that seeks to provide investment results that, before fees and expenses, correspond generally to the price and yield performance of its Target Index (as specified
        herein). The policies of the sponsor of its Target Index (an &#8220;Index Sponsor&#8221;) concerning the calculation of its Target Index, additions, deletions or substitutions of the components of its Target Index and the manner in which changes affecting
        those components, such as stock dividends, reorganizations or mergers, may be reflected in its Target Index and, therefore, could adversely affect the return on the Notes and the market value of the Notes prior to maturity. The market value of, and
        return on, the Notes could also be affected if the sponsor of its Target Index changes these policies, for example, by changing the manner in which it calculates its Target Index. Some of the risks that relate to a target index of an ETF include
        those discussed in the product supplement, which you should review.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <div>
            <div>
              <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

                  <tr>
                    <td style="width: 50.00%;">
                      <div style="font-size: 8pt; text-align: left;">TD SECURITIES (USA) LLC</div>
                    </td>
                    <td style="width: 50.00%;">
                      <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">7</font></div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">The Performance of the iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> MSCI EAFE ETF May Not Correlate With That of Its Target Index.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">The performance of the iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> MSCI EAFE ETF may not exactly replicate the performance of its Target Index because the iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> MSCI EAFE ETF will reflect transaction costs
        and fees that are not included in the calculation of its Target Index. It is also possible that the iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> MSCI EAFE ETF may not fully replicate or may in certain circumstances diverge significantly from the performance of its Target
        Index due to the temporary unavailability of certain securities in the secondary market, the performance of any derivative instruments contained in the iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> MSCI EAFE ETF, differences in trading hours between the iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup>
        MSCI EAFE ETF and its Target Index or due to other circumstances.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">There Are Liquidity and Management Risks Associated with an ETF and the iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> MSCI EAFE ETF Utilizes a Passive Indexing Investment Approach.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">&#160;Although shares of the iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> MSCI EAFE ETF are listed for trading on a securities exchange and a number of similar products have been traded on various exchanges for varying periods
        of time, there is no assurance that an active trading market will continue for such shares or that there will be liquidity in that trading market. The iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> MSCI EAFE ETF is subject to management risk, which is the risk that its
        Investment Adviser&#8217;s investment strategy, the implementation of which is subject to a number of constraints, may not produce the intended results. Additionally, the iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> MSCI EAFE ETF is not managed according to traditional methods
        of &#8220;active&#8221; investment management, which involves the buying and selling of securities based on economic, financial and market analysis and investment judgment. Instead, utilizing a &#8220;passive&#8221; or indexing investment approach, it attempts to
        approximate the investment performance of its Target Index by investing in Reference Asset Constituents that generally replicate its Target Index. Therefore, unless a specific stock is removed from its Target Index, the iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> MSCI
        EAFE ETF generally would not sell a stock because that stock&#8217;s issuer was in financial trouble.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">The Notes May Be Subject to Non-U.S. Currency Exchange Rate Risk.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">The Reference Asset Constituents held by the iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> MSCI EAFE ETF may be traded and quoted in non-U.S. currencies on non-U.S. markets. The prices of such Reference Asset Constituents
        that are quoted and traded in a currency other than U.S. dollars are converted into U.S. dollars for purposes of calculating the price of the iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> MSCI EAFE ETF. As a result, holders of the Notes will be exposed to currency exchange
        rate risk with respect to each of the currencies in which such Reference Asset Constituents are denominated. The values of the currencies of such Reference Asset Constituents may be subject to a high degree of fluctuation due to changes in interest
        rates, the effects of monetary policies issued by the United States, non-U.S. governments, central banks or supranational entities, the imposition of currency controls or other national or global political or economic developments. The price of the
        iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> MSCI EAFE ETF will depend on the extent to which the relevant non-U.S. currencies, if any, strengthen or weaken against the U.S. dollar and the relative weight of each non-U.S. Reference Asset Constituent. If, taking into
        account such weighting, the U.S. dollar strengthens against the relevant non-U.S. currencies, the value of such Reference Asset Constituents, and therefore the price of the iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> MSCI EAFE ETF, will be adversely affected and the value
        of, and return on, the Notes may decrease.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">The U.K. Financial Conduct Authority and regulators from other countries are in the process of investigating the potential manipulation of published currency exchange rates. If such manipulation
        has occurred or is continuing, certain published exchange rates may have been, or may be in the future, artificially lower (or higher) than they would otherwise have been. Any such manipulation could have an adverse impact on the market value of,
        and return on, your Notes and the trading market for your Notes. In addition, we cannot predict whether any changes or reforms affecting the determination or publication of exchange rates or the supervision of currency trading will be implemented
        in connection with these investigations. Any such changes or reforms could also adversely impact your Notes.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">The Notes are Subject to Risks Associated with Non-U.S. Securities.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">The Notes are subject to risks associated with non-U.S. securities because the iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> MSCI EAFE ETF includes Reference Asset Constituents that are issued by non-U.S. companies. Market
        developments may affect non-U.S. companies differently from U.S. companies and direct or indirect government intervention to stabilize these non-U.S. markets, as well as cross shareholdings in non-U.S. companies, may affect trading prices and
        volumes in those markets. Securities issued by non-U.S. companies are subject to political, economic, financial and social factors that may be unique to the particular country. These factors, which could negatively affect the applicable Reference
        Asset Constituents include the possibility of recent or future changes in the non-U.S. government&#8217;s economic and fiscal policies, the possible imposition of, or changes in, currency exchange laws or other non-U.S. laws or restrictions applicable to
        non-U.S. companies or investments in non-U.S. equity securities and the possibility of fluctuations in the rate of exchange between currencies. Moreover, certain aspects of a particular non-U.S. economy may differ favorably or unfavorably from the
        U.S. economy in important respects, such as growth of gross national product, rate of inflation, capital reinvestment, resources and self-sufficiency.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">The EURO STOXX 50<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index Reflects Price Return, not Total Return.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">The return on the Notes is based on the performance of the EURO STOXX 50<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index, which reflects the changes in the market prices of its Reference Asset Constituents. The EURO STOXX 50<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup>
        Index is not a &#8220;total return&#8221; index or strategy, which, in addition to reflecting those price returns, would also reflect dividends paid on its Reference Asset Constituents. The return on the Notes will not include such a total return feature or
        dividend component.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">The Notes are Subject to Currency Exchange Risk.</div>
      <div style="text-align: justify;">The Notes are subject to currency exchange risk because the Reference Asset Constituents of the EURO STOXX 50<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index are quoted and traded in one or more non-U.S. currencies. Neither the level of such
        index nor the value of the Notes will be adjusted for exchange rate fluctuations between the U.S. dollar and the currencies in which such Reference Asset Constituents are based. Therefore, if the</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <div>
            <div>
              <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

                  <tr>
                    <td style="width: 50.00%;">
                      <div style="font-size: 8pt; text-align: left;">TD SECURITIES (USA) LLC</div>
                    </td>
                    <td style="width: 50.00%;">
                      <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">8</font></div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-bottom: 6pt;">applicable currencies appreciate or depreciate relative to the U.S. dollar over the term of the Notes, you will not receive any additional payment or incur any reduction in your return on the
        Notes.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">The Notes are Subject to Risks Associated with Non-U.S. Securities Markets.</div>
      <div style="text-align: justify; margin-top: 6pt;">The value of the Notes is linked to the EURO STOXX 50<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index and its Reference Asset Constituents, which are traded in one or more non-U.S. securities markets. Investments linked to the
        value of non-U.S. equity securities involve particular risks. Any non-U.S. securities market may be less liquid, more volatile and affected by global or domestic market developments in a different way than are the U.S. securities market or other
        non-U.S. securities markets. Both government intervention in a non-U.S. securities market, either directly or indirectly, and cross-shareholdings in non-U.S. companies, may affect trading prices and volumes in that market. Also, there is generally
        less publicly available information about non-U.S. companies than about those U.S. companies that are subject to the reporting requirements of the SEC. Further, non-U.S. companies are likely subject to accounting, auditing and financial reporting
        standards and requirements that differ from those applicable to U.S. reporting companies. The prices of securities in a non-U.S. country are subject to political, economic, financial and social factors that are unique to such non-U.S. country's
        geographical region. These factors include: recent changes, or the possibility of future changes, in the applicable non-U.S. government's economic and fiscal policies; the possible implementation of, or changes in, currency exchange laws or other
        laws or restrictions applicable to non-U.S. companies or investments in non-U.S. equity securities; fluctuations, or the possibility of fluctuations, in currency exchange rates; and the possibility of outbreaks of hostility, political instability,
        natural disaster or adverse public health developments. Any one of these factors, or the combination of more than one of these or other factors, could negatively affect such non-U.S. securities market and the prices of securities therein. Further,
        geographical regions may react to global factors in different ways, which may cause the prices of securities in a non-U.S. securities market to fluctuate in a way that differs from those of securities in the U.S. securities market or other non-U.S.
        securities markets. Non-U.S. economies may also differ from the U.S. economy in important respects, including growth of gross national product, rate of inflation, capital reinvestment, resources and self-sufficiency, which may have a negative
        effect on non-U.S. securities prices.</div>
      <div style="text-align: justify; margin-top: 6pt;">The Notes may also be subject to regulatory risks, including sanctions, because the EURO STOXX 50<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index is comprised, at least in part, of stocks that are traded in one or more non-U.S.
        securities markets. For instance, pursuant to U.S. executive orders, U.S. persons are prohibited from engaging in transactions in publicly traded securities of certain companies that are determined to be linked to the military, intelligence and
        security apparatus of the People&#8217;s Republic of China. The prohibition also covers any securities that are derivative of, or are designed to provide investment exposure to, such securities. Actions taken by its Index Sponsor in response to any such
        developments could adversely affect the performance of the EURO STOXX 50<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index and, as a result, the market value of, and return on the Notes. Additionally, following certain events, if the Calculation Agent determines that a change in
        law has occurred, then the Calculation Agent may select a successor index, reference a replacement basket or use an alternative method of calculation, or, if it determines that no successor index, replacement basket or alternative method of
        calculation is available, it may deem the Reference Asset&#8217;s Closing Value on a Trading Day reasonably proximate to the date of such event to be its Closing Value on each applicable date. For additional information, see the section &#8220;General Terms of
        the Notes &#8212; Unavailability of the Level of, or Change in Law Event Affecting, the Reference Asset; Modification to Method of Calculation&#8221; in the corresponding product supplement.</div>
      <div style="text-align: center; margin-top: 12pt; margin-bottom: 12pt; font-style: italic; font-weight: bold;">Risks Relating to Estimated Value and Liquidity</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">The Estimated Value of Your Notes Is Expected to Be Less Than the Public Offering Price of Your Notes.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">The estimated value of your Notes on the Pricing Date is expected to be less than the public offering price of your Notes. The difference between the public offering price of your Notes and the
        estimated value of the Notes reflects costs and expected profits associated with selling and structuring the Notes, as well as hedging our obligations under the Notes. Because hedging our obligations entails risks and may be influenced by market
        forces beyond our control, this hedging may result in a profit that is more or less than expected, or a loss.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">The Estimated Value of Your Notes Is Based on Our Internal Funding Rate.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">The estimated value of your Notes on the Pricing Date is determined by reference to our internal funding rate. The internal funding rate used in the determination of the estimated value of the
        Notes generally represents a discount from the credit spreads for our conventional, fixed-rate debt securities and the borrowing rate we would pay for our conventional, fixed-rate debt securities. This discount is based on, among other things, our
        view of the funding value of the Notes as well as the higher issuance, operational and ongoing liability management costs of the Notes in comparison to those costs for our conventional, fixed-rate debt, as well as estimated financing costs of any
        hedge positions, taking into account regulatory and internal requirements. If the interest rate implied by the credit spreads for our conventional, fixed-rate debt securities, or the borrowing rate we would pay for our conventional, fixed-rate debt
        securities were to be used, we would expect the economic terms of the Notes to be more favorable to you. Additionally, assuming all other economic terms are held constant, the use of an internal funding rate for the Notes is expected to increase
        the estimated value of the Notes at any time.</div>
      <div style="text-align: justify; font-weight: bold;">The Estimated Value of the Notes Is Based on Our Internal Pricing Models, Which May Prove to Be Inaccurate and May Be</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <div>
            <div>
              <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

                  <tr>
                    <td style="width: 50.00%;">
                      <div style="font-size: 8pt; text-align: left;">TD SECURITIES (USA) LLC</div>
                    </td>
                    <td style="width: 50.00%;">
                      <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">9</font></div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Different From the Pricing Models of Other Financial Institutions.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">The estimated value of your Notes on the Pricing Date is based on our internal pricing models when the terms of the Notes are set, which take into account a number of variables, such as our
        internal funding rate on the Pricing Date, and are based on a number of subjective assumptions, which are not evaluated or verified on an independent basis and may or may not materialize. Further, our pricing models may be different from other
        financial institutions&#8217; pricing models and the methodologies used by us to estimate the value of the Notes may not be consistent with those of other financial institutions that may be purchasers or sellers of Notes in the secondary market. As a
        result, the secondary market price of your Notes may be materially less than the estimated value of the Notes determined by reference to our internal pricing models. In addition, market conditions and other relevant factors in the future may
        change, and any assumptions may prove to be incorrect.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">The Estimated Value of Your Notes Is Not a Prediction of the Prices at Which You May Sell Your Notes in the Secondary Market, if Any, and Such Secondary Market Prices, if Any,
        Will Likely Be Less Than the Public Offering Price of Your Notes and May Be Less Than the Estimated Value of Your Notes.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">The estimated value of the Notes is not a prediction of the prices at which the Agent, other affiliates of ours or third parties may be willing to purchase the Notes from you in secondary market
        transactions (if they are willing to purchase, which they are not obligated to do). The price at which you may be able to sell your Notes in the secondary market at any time, if any, will be influenced by many factors that cannot be predicted, such
        as market conditions, and any bid and ask spread for similar sized trades, and may be substantially less than the estimated value of the Notes. Further, as secondary market prices of your Notes take into account the levels at which our debt
        securities trade in the secondary market, and do not take into account our various costs and expected profits associated with selling and structuring the Notes, as well as hedging our obligations under the Notes, secondary market prices of your
        Notes will likely be less than the public offering price of your Notes. As a result, the price at which the Agent, other affiliates of ours or third parties may be willing to purchase the Notes from you in secondary market transactions, if any,
        will likely be less than the price you paid for your Notes, and any sale prior to the Maturity Date could result in a substantial loss to you.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">The Temporary Price at Which the Agent May Initially Buy the Notes in the Secondary Market May Not Be Indicative of Future Prices of Your Notes.</div>
      <div style="text-align: justify; margin-top: 6pt;">Assuming that all relevant factors remain constant after the Pricing Date, the price at which the Agent may initially buy or sell the Notes in the secondary market (if the Agent makes a market in the
        Notes, which it is not obligated to do) may exceed the estimated value of the Notes on the Pricing Date, as well as the secondary market value of the Notes, for a temporary period after the Issue Date of the Notes, as discussed further under
        &#8220;Additional Information Regarding the Estimated Value of the Notes.&#8221; The price at which the Agent may initially buy or sell the Notes in the secondary market may not be indicative of future prices of your Notes.</div>
      <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">The Underwriting Discount, Offering Expenses and Certain Hedging Costs Are Likely to Adversely Affect Secondary Market Prices.</div>
      <div style="text-align: justify; margin-top: 6pt;">Assuming no changes in market conditions or any other relevant factors, the price, if any, at which you may be able to sell the Notes will likely be less than the public offering price. The public
        offering price includes, and any price quoted to you is likely to exclude, any underwriting discount paid in connection with the initial distribution, offering expenses as well as the cost of hedging our obligations under the Notes. In addition,
        any such price is also likely to reflect dealer discounts, mark-ups and other transaction costs, such as a discount to account for costs associated with establishing or unwinding any related hedge transaction.</div>
      <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">There May Not Be an Active Trading Market for the Notes &#8212; Sales in the Secondary Market May Result in Significant Losses.</div>
      <div style="text-align: justify; margin-top: 6pt;">There may be little or no secondary market for the Notes. The Notes will not be listed or displayed on any securities exchange or electronic communications network. The Agent or another one of our
        affiliates may make a market for the Notes; however, it is not required to do so and may stop any market-making activities at any time. Even if a secondary market for the Notes develops, it may not provide significant liquidity or trade at prices
        advantageous to you. We expect that transaction costs in any secondary market would be high. As a result, the difference between bid and ask prices for your Notes in any secondary market could be substantial.</div>
      <div style="text-align: justify; margin-top: 6pt;">If you sell your Notes before the Maturity Date, you may have to do so at a substantial discount from the public offering price irrespective of the value of the then-current least performing
        Reference Asset, and as a result, you may suffer substantial losses.</div>
      <div style="text-align: justify; margin-top: 6pt; color: rgb(0, 0, 0); font-weight: bold;">If the Value of Any Reference Asset Changes, the Market Value of Your Notes May Not Change in the Same Manner.</div>
      <div style="text-align: justify; margin-top: 6pt;">Your Notes may trade quite differently from the performance of any of the Reference Assets. Any payment on the Notes will be based solely on the Final Value of the Least Performing Reference Asset on
        the Final Valuation Date. Changes in the value of any Reference <font style="color: rgb(0, 0, 0);">Asset may not result in a comparable change in the market value of your Notes. Even if the Closing Value of each Reference Asset remains greater
          than or equal to its Barrier Value or increases to greater than its Initial Value during the term of the Notes, the market value of your Notes may not increase by the same amount and could decline.</font></div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <div>
            <div>
              <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

                  <tr>
                    <td style="width: 50.00%;">
                      <div style="font-size: 8pt; text-align: left;">TD SECURITIES (USA) LLC</div>
                    </td>
                    <td style="width: 50.00%;">
                      <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">10</font></div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; margin-bottom: 12pt; font-style: italic; font-weight: bold;">Risks Relating to Hedging Activities and Conflicts of Interest</div>
      <div style="text-align: justify; margin-top: 10pt; font-weight: bold;">There Are Potential Conflicts of Interest Between You and the Calculation Agent.</div>
      <div style="text-align: justify; margin-top: 6pt;">The Calculation Agent will, among other things, determine the Payment at Maturity on the Notes. We will serve as the Calculation Agent and may appoint a different Calculation Agent after the Issue
        Date without notice to you. The Calculation Agent will exercise its judgment when performing its functions and may have a conflict of interest if it needs to make certain decisions. For example, the Calculation Agent may have to determine whether a
        market disruption event affecting a Reference Asset has occurred, and make certain adjustments if certain events occur, which may, in turn, depend on the Calculation Agent&#8217;s judgment as to whether the event has materially interfered with our
        ability or the ability of one of our affiliates to unwind our hedge positions. Because this determination by the Calculation Agent may affect the amount payable on the Notes, the Calculation Agent may have a conflict of interest if it needs to make
        a determination of this kind. For additional information on the Calculation Agent&#8217;s role, see &#8220;General Terms of the Notes &#8212; Role of Calculation Agent&#8221; in the product supplements.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">You Will Have Limited Anti-Dilution Protection and, in Certain Situations, Including a Change in Law Event, Your Return on the Notes May be Based on a Substitute Reference
        Asset.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">The Calculation Agent may adjust the Initial Value, and therefore the Barrier Value of an Equity Reference Asset for stock splits, reverse stock splits, stock dividends, extraordinary dividends
        and other events that affect such Equity Reference Asset, but only in the situations we describe in &#8220;General Terms of the Notes &#8212; Anti-Dilution Adjustments&#8221; in the product supplement MLN-ES-ETF-1. The Calculation Agent will not be required to make
        an adjustment for every event that may affect an Equity Reference Asset. Furthermore, in certain situations, such as when a Reference Asset undergoes a Reorganization Event or a Reference Asset is delisted, such Reference Asset may be replaced by
        distribution property or a substitute equity security, as discussed more fully in the product supplement MLN-ES-ETF-1 under &#8220;General Terms of the Notes&#8221;. Similarly, the Calculation Agent may select a Substitute Equity Security if a Change in Law
        Event (as defined in the product supplement) occurs with respect to a Reference Asset. Notwithstanding the Calculation Agent&#8217;s ability to make adjustments to the terms of the Notes and the Reference Assets, those events or other actions affecting a
        Reference Asset, or a third party may nevertheless adversely affect the price of the applicable Reference Asset and, therefore, adversely affect the market value of, and return on, your Notes.</div>
      <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">Market Disruption Events and Postponements.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">The Final Valuation Date, and therefore the Maturity Date, are subject to postponement as described in the applicable product supplement due to the occurrence of one or more market disruption
        events. For a description of what constitutes a market disruption event as well as the consequences of that market disruption event, see &#8220;General Terms of the Notes&#8212;Market Disruption Events&#8221; in the applicable product supplement. A market disruption
        event for a particular Reference Asset will not constitute a market disruption event for any other Reference Asset.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Trading and Business Activities by TD or Its Affiliates May Adversely Affect the Market Value Of, and Any Amounts Payable On, the Notes.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">We, the Agent and/or our other affiliates may hedge our obligations under the Notes by purchasing securities, futures, options or other derivative instruments with returns linked or related to
        changes in the value of a Reference Asset or one or more Reference Asset Constituents, and we may adjust these hedges by, among other things, purchasing or selling at any time any of the foregoing assets. It is possible that we or one or more of
        our affiliates could receive substantial returns from these hedging activities while the market value of the Notes declines. We or one or more of our affiliates may also issue or underwrite other securities or financial or derivative instruments
        with returns linked or related to changes in a Reference Asset or one or more Reference Asset Constituents.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">These trading activities may present a conflict between the holders&#8217; interest in the Notes and the interests we and our affiliates will have in our or their proprietary accounts, in facilitating
        transactions, including options and other derivatives transactions, for our or their customers&#8217; accounts and in accounts under our or their management. These trading activities could be adverse to the interests of the holders of the Notes.</div>
      <div style="text-align: justify; margin-top: 6pt;"><font style="color: rgb(0, 0, 0);">We, the Agent and/or our other affiliates may, </font>at present or in the future, engage in business with one or more Reference Asset Constituent Issuers,
        including making loans to or providing advisory services to those companies. These services could include investment banking and merger and acquisition advisory services. These business activities may present a conflict between <font style="color: rgb(0, 0, 0);">our, the Agent&#8217;s and/or our other affiliates&#8217; obligations</font>, and your interests as a holder of the Notes. Moreover, we, the Agent and/or our <font style="color: rgb(0, 0, 0);">other </font>affiliates may have published, and
        in the future expect to publish, research reports with respect to a Reference Asset or one or more Reference Asset Constituents. This research is modified from time to time without notice and may express opinions or provide recommendations that are
        inconsistent with purchasing or holding the Notes. Any of these activities by us and/or our <font style="color: rgb(0, 0, 0);">other </font>affiliates may affect the value of a Reference Asset or one or more Reference Asset Constituents and,
        therefore, the market value of, and any amounts payable on, the Notes.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <div>
            <div>
              <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

                  <tr>
                    <td style="width: 50.00%;">
                      <div style="font-size: 8pt; text-align: left;">TD SECURITIES (USA) LLC</div>
                    </td>
                    <td style="width: 50.00%;">
                      <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">11</font></div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-style: italic; font-weight: bold;">Risks Relating to General Credit Characteristics</div>
      <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">Investors Are Subject to TD&#8217;s Credit Risk, and TD&#8217;s Credit Ratings and Credit Spreads May Adversely Affect the Market Value of the Notes.</div>
      <div style="text-align: justify; margin-top: 6pt;">Although the return on the Notes will be based on the performance of the Least Performing Reference Asset, the payment of any amount due on the Notes is subject to TD&#8217;s credit risk. The Notes are
        TD&#8217;s senior unsecured debt obligations. Investors are dependent on TD&#8217;s ability to pay all amounts due on the Notes and, therefore, investors are subject to the credit risk of TD and to changes in the market&#8217;s view of TD&#8217;s creditworthiness. Any
        decrease in TD&#8217;s credit ratings or increase in the credit spreads charged by the market for taking TD&#8217;s credit risk is likely to adversely affect the market value of the Notes. If TD becomes unable to meet its financial obligations as they become
        due, investors may not receive any amounts due under the terms of the Notes.</div>
      <div style="text-align: center; margin-top: 6pt; font-style: italic; font-weight: bold;">Risks Relating to Canadian and U.S. Federal Income Taxation</div>
      <div style="margin-bottom: 5pt;"><br>
      </div>
      <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">Significant Aspects of the Tax Treatment of the Notes Are Uncertain.</div>
      <div style="text-align: justify; margin-top: 6pt;">The U.S. tax treatment of the Notes is uncertain. Please read carefully the section entitled &#8220;Material U.S. Federal Income Tax Consequences&#8221; herein and in the product supplements. You should consult
        your tax advisor as to the tax consequences of your investment in the Notes.</div>
      <div style="text-align: justify; margin-top: 6pt;">For a discussion of the Canadian federal income tax consequences of investing in the Notes, please see the discussion in the prospectus under &#8220;Tax Consequences &#8212; Canadian Taxation&#8221; and in the product
        supplements under &#8220;Supplemental Discussion of Canadian Tax Consequences&#8221; and the further discussion herein under &#8220;Summary&#8221;. If you are not a Non-resident Holder (as that term is defined in the prospectus) for Canadian federal income tax purposes or
        if you acquire the Notes in the secondary market, you should consult your tax advisors as to the consequences of acquiring, holding and disposing of the Notes and receiving the payments that might be due under the Notes.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <div>
            <div>
              <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

                  <tr>
                    <td style="width: 50.00%;">
                      <div style="font-size: 8pt; text-align: left;">TD SECURITIES (USA) LLC</div>
                    </td>
                    <td style="width: 50.00%;">
                      <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">12</font></div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-bottom: 8pt; color: rgb(0, 176, 80); font-size: 16pt;">Hypothetical Returns</div>
      <div style="margin: 6pt 0px; text-align: justify;">The examples and table set out below are included for illustration purposes only and are hypothetical examples only: amounts below may have been rounded for ease of analysis. The hypothetical
        Percentage Changes of the Reference Assets used to illustrate the calculation of the Payment at Maturity are not estimates or forecasts of the Initial Value or Final Value of any Reference Asset, or the values of the Reference Assets on any Trading
        Day prior to the Maturity Date. All examples reflect the Leverage Factor of 222.00%, Barrier Values equal to 70.00% of the respective Initial Values, that a holder purchased Notes with a Principal Amount of $1,000 and that no market disruption
        event occurs on the Final Valuation Date. The actual terms of the Notes will be set forth in the final pricing supplement.</div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="ze07494e5c73849ac92604f7db1a566ff">

          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Example 1 &#8212;</div>
            </td>
            <td colspan="2" style="vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Calculation of the Payment at Maturity where the Final Value of each Reference Asset is greater than its Initial Value.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;"><br>
            </td>
            <td style="width: 21%; vertical-align: top;">
              <div style="margin-bottom: 6pt;">Least Performing Percentage Change:</div>
            </td>
            <td style="width: 67%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 6pt;">5.00%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;"><br>
            </td>
            <td style="width: 21%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 6pt;">Payment at Maturity:</div>
            </td>
            <td style="width: 67%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 6pt;">= $1,000.00 + ($1,000.00 &#215; 5.00% &#215; 222.00%)</div>
              <div style="text-align: justify; margin-bottom: 6pt;">= $1,000.00 + $111.00</div>
              <div style="text-align: justify; margin-bottom: 6pt;">= $1,111.00</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;"><br>
            </td>
            <td colspan="2" style="vertical-align: top;">
              <div style="text-align: justify;">On a $1,000.00 investment, a Least Performing Percentage Change of 5.00% results in a Payment at Maturity of $1,111.00, a return of 11.10% on the Notes.</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zd20e4577f8b846c6a71a3c24310d8a0f">

          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Example 2 &#8212;</div>
            </td>
            <td colspan="2" style="vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Calculation of the Payment at Maturity where the Final Value of any Reference Asset is less than or equal to its Initial Value but the Final Value of each Reference
                Asset is greater than or equal to its Barrier Value.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;"><br>
            </td>
            <td style="width: 21%; vertical-align: top;">
              <div style="margin-bottom: 6pt;">Least Performing Percentage Change:</div>
            </td>
            <td style="width: 67%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 6pt;">-5.00%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;"><br>
            </td>
            <td style="width: 21%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 6pt;">Payment at Maturity:</div>
            </td>
            <td style="width: 67%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 6pt;">At maturity, if the Final Value of any Reference Asset is less than or equal to its Initial Value but the Final Value of each Reference Asset is greater than or equal to its Barrier Value,
                then the Payment at Maturity will equal the Principal Amount.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;"><br>
            </td>
            <td colspan="2" style="vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 6pt;">On a $1,000.00 investment, a Least Performing Percentage Change of -5.00% results in a Payment at Maturity of $1,000.00, a return of 0.00% on the Notes.</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z59ab13047e014f9e802828f078367baf">

          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Example 3 &#8212;</div>
            </td>
            <td colspan="2" style="vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Calculation of the Payment at Maturity where the Final Value of any Reference Asset is less than its Barrier Value.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;"><br>
            </td>
            <td style="width: 21%; vertical-align: top;">
              <div style="margin-bottom: 6pt;">Least Performing Percentage Change:</div>
            </td>
            <td style="width: 67%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 6pt;">-60.00%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;"><br>
            </td>
            <td style="width: 21%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 6pt;">Payment at Maturity:</div>
            </td>
            <td style="width: 67%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 6pt;">= $1,000.00 + ($1,000.00 &#215; -60.00%)</div>
              <div style="text-align: justify; margin-bottom: 6pt;">= $1,000.00 - $600.00</div>
              <div style="text-align: justify; margin-bottom: 6pt;">= $400.00</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;"><br>
            </td>
            <td colspan="2" style="vertical-align: top;">
              <div style="text-align: justify;">On a $1,000.00 investment, a Least Performing Percentage Change of -60.00%&#160; results in a Payment at Maturity of $400.00, a loss of 60.00% on the Notes. <font style="font-weight: bold;">In this scenario,
                  investors will suffer a percentage loss on their initial investment that is equal to the Least Performing Percentage Change. Specifically, investors will lose 1% of the Principal Amount of the Notes for each 1% that the Final Value of the
                  Least Performing Reference Asset is less than its Initial Value, and may lose the entire Principal Amount. Any payment on the Notes is subject to our credit risk.</font></div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <div>
            <div>
              <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

                  <tr>
                    <td style="width: 50.00%;">
                      <div style="font-size: 8pt; text-align: left;">TD SECURITIES (USA) LLC</div>
                    </td>
                    <td style="width: 50.00%;">
                      <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">13</font></div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify;">The following table shows the hypothetical return profile for the Notes on the Maturity Date, based on the hypothetical terms set forth above and assuming that the investor purchased the Notes at the public offering
        price and held the Notes until the Maturity Date. The hypothetical returns on the Notes illustrated in the following table are not estimates or forecasts of the Percentage Change of the Least Performing Reference Asset or the return or loss on the
        Notes. Neither TD nor the Agent is predicting or guaranteeing any gain or particular return on the Notes.</div>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" align="center" style="border-collapse: collapse; width: 60%; color: #000000; font-family: Arial; font-size: 9pt; text-align: left;" id="z8c42ac2029e44780b1b618acc133f435">

          <tr>
            <td style="width: 20%; vertical-align: middle; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="margin: 8pt 0px 0px; font-weight: bold; text-align: center;">Hypothetical Least </div>
              <div style="text-align: center; font-weight: bold;">Performing </div>
              <div style="margin: 0px 0px 4pt; font-weight: bold; text-align: center;">Percentage Change</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-right: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="margin: 8pt 0px 0px; font-weight: bold; text-align: center;">Hypothetical Payment</div>
              <div style="text-align: center; font-weight: bold;"> at Maturity ($)</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-right: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="margin: 8pt 0px 0px; font-weight: bold; text-align: center;">Hypothetical Return</div>
              <div style="text-align: center; font-weight: bold;"> on Notes (%)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 20%; vertical-align: top; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-top: 1pt; margin-bottom: 1pt;">40.00%</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center;">$1,888.00</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center;">88.80%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 20%; vertical-align: top; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-top: 1pt; margin-bottom: 1pt;">30.00%</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center;">$1,666.00</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center;">66.60%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 20%; vertical-align: top; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-top: 1pt; margin-bottom: 1pt;">20.00%</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center;">$1,444.00</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center;">44.40%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 20%; vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="text-align: center; margin-top: 1pt; margin-bottom: 1pt;">10.00%</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-right: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center;">$1,222.00</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-right: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center;">22.20%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 20%; vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="text-align: center; margin-top: 1pt; margin-bottom: 1pt;">5.00%</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-right: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center;">$1,111.00</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-right: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center;">11.10%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 20%; vertical-align: top; background-color: rgb(191, 191, 191); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-top: 1pt; margin-bottom: 1pt;">0.00%</div>
            </td>
            <td style="width: 20%; vertical-align: middle; background-color: rgb(191, 191, 191); border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-top: 1pt; margin-bottom: 1pt;">$1,000.00</div>
            </td>
            <td style="width: 20%; vertical-align: middle; background-color: rgb(191, 191, 191); border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-top: 1pt; margin-bottom: 1pt;">0.00%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 20%; vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="text-align: center; margin-top: 1pt; margin-bottom: 1pt;">-10.00%</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-right: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-top: 1pt; margin-bottom: 1pt;">$1,000.00</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-right: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-top: 1pt; margin-bottom: 1pt;">0.00%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 20%; vertical-align: top; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-top: 1pt; margin-bottom: 1pt;">-20.00%</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-right: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-top: 1pt; margin-bottom: 1pt;">$1,000.00</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-right: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-top: 1pt; margin-bottom: 1pt;">0.00%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 20%; vertical-align: top; background-color: rgb(191, 191, 191); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-top: 1pt; margin-bottom: 1pt;">-30.00%</div>
            </td>
            <td style="width: 20%; vertical-align: middle; background-color: rgb(191, 191, 191); border-right: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-top: 1pt; margin-bottom: 1pt;">$1,000.00</div>
            </td>
            <td style="width: 20%; vertical-align: middle; background-color: rgb(191, 191, 191); border-right: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-top: 1pt; margin-bottom: 1pt;">0.00%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 20%; vertical-align: middle; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="text-align: center; margin-top: 1pt; margin-bottom: 1pt;">-40.00%</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-right: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-top: 1pt; margin-bottom: 1pt;">$600.00</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-right: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-top: 1pt; margin-bottom: 1pt;">-40.00%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 20%; vertical-align: middle; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="text-align: center; margin-top: 1pt; margin-bottom: 1pt;">-50.00%</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-right: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-top: 1pt; margin-bottom: 1pt;">$500.00</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-right: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-top: 1pt; margin-bottom: 1pt;">-50.00%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 20%; vertical-align: middle; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-top: 1pt; margin-bottom: 1pt;">-75.00%</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-top: 1pt; margin-bottom: 1pt;">$250.00</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-top: 1pt; margin-bottom: 1pt;">-75.00%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 20%; vertical-align: middle; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="text-align: center; margin-top: 1pt; margin-bottom: 1pt;">-100.00%</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-right: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-top: 1pt; margin-bottom: 1pt;">$0.00</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-right: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-top: 1pt; margin-bottom: 1pt;">-100.00%</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <div>
            <div>
              <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

                  <tr>
                    <td style="width: 50.00%;">
                      <div style="font-size: 8pt; text-align: left;">TD SECURITIES (USA) LLC</div>
                    </td>
                    <td style="width: 50.00%;">
                      <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">14</font></div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-bottom: 12pt; color: rgb(0, 176, 80); font-size: 16pt;">Information Regarding the Reference Assets</div>
      <div style="text-align: justify; margin-top: 6pt; margin-bottom: 6pt;">All disclosures contained in this document regarding the Reference Assets, including, without limitation, their make-up, methods of calculation, and changes in any Reference Asset
        Constituents, have been derived from publicly available sources. We have not undertaken an independent review or due diligence of any publicly available information with respect to any Reference Asset.</div>
      <div style="text-align: justify; margin-top: 6pt; margin-bottom: 6pt;">Such information reflects the policies of, and is subject to change by, its Index Sponsor or Investment Adviser, as applicable. The Index Sponsor or Investment Adviser, as
        applicable, owns the copyright and all other rights to the relevant Reference Asset, has no obligation to continue to publish, and may discontinue publication of, the relevant Reference Asset. None of the websites referenced in the Reference Asset
        descriptions below, or any materials included in those websites, are incorporated by reference into this document or any document incorporated herein by reference. We have not independently verified the accuracy or completeness of reports filed by
        an Investment Adviser with the SEC, information published by it on its website or in any other format, information about it obtained from any other source or the information provided below.</div>
      <div style="text-align: justify; margin-top: 6pt; margin-bottom: 6pt;">The graphs below set forth the information relating to the historical performance of each Reference Asset. The graphs below show the daily historical Closing Values of each
        Reference Asset for the periods specified. We obtained the information regarding the historical performance of each Reference Asset in the graphs below from Bloomberg. The Closing Values for an Equity Reference Asset may be adjusted by Bloomberg
        for corporate actions such as stock splits, public offerings, mergers and acquisitions, spin-offs, delistings and bankruptcy.</div>
      <div style="text-align: justify;">We have not independently verified the accuracy or completeness of the information obtained from Bloomberg. The historical performance of each Reference Asset should not be taken as an indication of its future
        performance, and no assurance can be given as to the Final Value of any Reference Asset. We cannot give you any assurance that the performance of the Reference Assets will result in a positive return on your initial investment.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <div>
            <div>
              <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

                  <tr>
                    <td style="width: 50.00%;">
                      <div style="font-size: 8pt; text-align: left;">TD SECURITIES (USA) LLC</div>
                    </td>
                    <td style="width: 50.00%;">
                      <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">15</font></div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div>
        <div>
          <table cellspacing="0" cellpadding="0" border="0" style="border-collapse: collapse; margin: 0px 0px 6pt; width: 5%; color: #000000; font-family: Arial; font-size: 9pt; text-align: left;">

              <tr>
                <td nowrap="nowrap" style="width: 5%; vertical-align: top; border-bottom: 1px solid rgb(0, 0, 0);">
                  <div style="text-align: justify; font-weight: bold;">iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> MSCI EAFE ETF</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="text-align: justify; margin-top: 6pt;">We have derived all information contained herein regarding the iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> MSCI EAFE ETF (the &#8220;EFA Fund&#8221;) and the target index, as defined below, from publicly available information. Such
        information reflects the policies of, and is subject to changes by, the EFA Fund&#8217;s investment adviser, BlackRock Fund Advisors (&#8220;BFA&#8221; or the &#8220;investment adviser&#8221;) and the index sponsor of the target index, as defined below.</div>
      <div style="text-align: justify; margin-top: 6pt;">The EFA Fund is one of the separate investment portfolios that constitute the iShares Trust (&#8220;iShares&#8221;). The EFA Fund seeks to provide investment results that correspond generally to the price and
        yield performance, before fees and expenses, of the MSCI EAFE<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index (the &#8220;target index&#8221;). The target index seeks to measure the equity market performance of developed markets outside of the U.S. and Canada. The target index was created
        by, and is calculated, maintained and published by, MSCI Inc. (the &#8220;index sponsor&#8221;). The index sponsor is under no obligation to continue to publish, and may discontinue or suspend the publication of, the target index at any time.</div>
      <div style="text-align: justify; margin-top: 6pt;">Select information regarding the EFA Fund&#8217;s expense ratio and its top constituents, country, industry and/or sector weightings may be made available on the EFA Fund&#8217;s website. Expenses of the EFA
        Fund reduce the net asset value of the assets held by the EFA Fund and, therefore, reduce the value of the shares of the EFA Fund.</div>
      <div style="text-align: justify; margin-top: 6pt;">BFA uses a representative sampling strategy to manage the EFA Fund. &#8220;Representative sampling&#8221; is an indexing strategy that involves investing in a representative sample of the securities included in
        the target index that the investment adviser determines to collectively have an investment profile similar to that of the target index. The securities selected are intended to have, in the aggregate, investment characteristics (based on market
        capitalization and industry weightings), fundamental characteristics (such as return variability and yield) and liquidity measures similar to those of the target index. The EFA Fund may or may not hold all of the securities that are included in the
        target index.</div>
      <div style="text-align: justify; margin-top: 6pt;">The EFA Fund will generally invest at least 80% of its assets in the securities of the target index and depositary receipts representing the securities of the target index. The EFA Fund also may
        invest the remainder of its assets in certain futures, options and swap contracts, cash and cash equivalents, including money market funds advised by BFA or its affiliates, as well as in securities not included in the target index, but which BFA
        believes will help the EFA Fund track the target index. The EFA Fund will concentrate its investments (i.e., hold 25% or more of its total assets) in the stocks of a particular industry or group of industries to approximately the same extent that
        the target index is concentrated.</div>
      <div style="text-align: justify; margin-top: 6pt;">Shares of the EFA Fund are listed on the NYSE Arca under the ticker symbol &#8220;EFA&#8221;.</div>
      <div style="text-align: justify; margin-top: 6pt;">Information from outside sources including, but not limited to the prospectus related to the EFA Fund and any other website referenced in this section, is not incorporated by reference in, and should
        not be considered part of, this document or any document incorporated herein by reference. We have not undertaken an independent review or due diligence of any publicly available information with respect to the EFA Fund or the target index.</div>
      <div style="text-align: justify; margin-top: 6pt;">Information filed by iShares, Inc. with the SEC, including the prospectus for the EFA Fund, can be found by reference to its SEC file numbers: 333-92935 and 811-09729 or its CIK Code: 0001100663.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <div>
            <div>
              <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

                  <tr>
                    <td style="width: 50.00%;">
                      <div style="font-size: 8pt; text-align: left;">TD SECURITIES (USA) LLC</div>
                    </td>
                    <td style="width: 50.00%;">
                      <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">16</font></div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; font-weight: bold;">Historical Information</div>
      <div style="text-align: justify; margin-top: 6pt;">The graph below illustrates the performance of EFA from October 9, 2015 through October 9, 2025.</div>
      <div style="text-align: center; margin-top: 6pt; font-size: 10pt; font-weight: bold;">iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> MSCI EAFE ETF (EFA)</div>
      <div style="margin-bottom: 6pt; text-align: center;"><img src="image00001.jpg"></div>
      <div style="margin: 10pt 0px 0px; font-style: italic; font-weight: bold; text-align: center;">PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <div>
            <div>
              <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

                  <tr>
                    <td style="width: 50.00%;">
                      <div style="font-size: 8pt; text-align: left;">TD SECURITIES (USA) LLC</div>
                    </td>
                    <td style="width: 50.00%;">
                      <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">17</font></div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="margin-bottom: 8pt; font-weight: bold;">
        <div>
          <table cellspacing="0" cellpadding="0" border="0" style="border-collapse: collapse; margin: 0px 0px 6pt; width: 5%; color: #000000; font-family: Arial; font-size: 9pt; text-align: left;">

              <tr>
                <td nowrap="nowrap" style="width: 5%; vertical-align: top; border-bottom: 1px solid rgb(0, 0, 0);">
                  <div style="font-weight: bold;">EURO STOXX 50<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="text-align: justify; margin-bottom: 10pt;">We have derived all information contained herein regarding the EURO STOXX 50<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index (&#8220;SX5E&#8221;), including without limitation, its make-up, method of calculation and changes in its
        components from publicly available information. Such information reflects the policies of, and is subject to change by STOXX Limited.</div>
      <div style="text-align: justify; margin-bottom: 10pt;">STOXX Limited has no obligation to continue to publish the SX5E, and may discontinue publication of the SX5E at any time. The SX5E is determined, comprised and calculated by STOXX Limited without
        regard to this instrument.</div>
      <div style="text-align: justify; margin-top: 6pt;">As discussed more fully in the underlier supplement under the heading &#8220;Indices &#8212; The EURO STOXX 50<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index&#8221;, the SX5E covers 50 stocks of market sector leaders mainly from 11 Eurozone
        countries: Austria, Belgium, Finland, France, Germany, Ireland, Italy, Luxembourg, the Netherlands, Portugal and Spain. Select information regarding top constituents and industry and/or sector weightings may be made available by the Index Sponsor
        on its website.</div>
      <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">Historical Information</div>
      <div style="text-align: justify; margin-top: 6pt;">The graph below illustrates the performance of SX5E from October 9, 2015 through October 9, 2025.</div>
      <div style="text-align: center; margin-top: 6pt; font-size: 10pt; font-weight: bold;">EURO STOXX 50<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index (SX5E)</div>
      <div style="margin-bottom: 6pt; text-align: center;"><img src="image00002.jpg"></div>
      <div style="margin: 10pt 0px 0px; font-style: italic; font-weight: bold; text-align: center;">PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <div>
            <div>
              <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

                  <tr>
                    <td style="width: 50.00%;">
                      <div style="font-size: 8pt; text-align: left;">TD SECURITIES (USA) LLC</div>
                    </td>
                    <td style="width: 50.00%;">
                      <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">18</font></div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-bottom: 12pt; color: rgb(0, 176, 80); font-size: 16pt;">Material U.S. Federal Income Tax Consequences</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">The U.S. federal income tax consequences of your investment in the Notes are uncertain. No statutory, regulatory, judicial or administrative authority directly discusses how the
        Notes should be treated for U.S. federal income tax purposes. Some of these tax consequences are summarized below, but we urge you to read the more detailed discussion under &#8220;Material U.S. Federal Income Tax Consequences&#8221; in the product supplements
        and discuss the tax consequences of your particular situation with your tax advisor. This discussion is based upon the U.S. Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;), final, temporary and proposed U.S. Department of the Treasury (the
        &#8220;Treasury&#8221;) regulations, rulings and decisions, in each case, as available and in effect as of the date hereof, all of which are subject to change, possibly with retroactive effect. Tax consequences under state, local and non-U.S. laws are not
        addressed herein. No ruling from the U.S. Internal Revenue Service (the &#8220;IRS&#8221;) has been sought as to the U.S. federal income tax consequences of your investment in the Notes, and the following discussion is not binding on the IRS.</div>
      <div style="text-align: justify;"><font style="font-style: italic;">U.S. Tax Treatment.</font><font style="font-weight: bold;">&#160;</font>Pursuant to the terms of the Notes, TD and you agree, in the absence of a statutory or regulatory change or an
        administrative determination or judicial ruling to the contrary, to characterize your Notes as prepaid derivative contracts with respect to the Reference Assets. If your Notes are so treated, you should generally recognize gain or loss upon the
        taxable disposition (including cash settlement) of your Notes in an amount equal to the difference between the amount you receive at such time and the amount you paid for your Notes. Subject to the discussion below regarding Section 1260 of the
        Code with respect to the Equity Reference Asset, such gain or loss should generally be long-term capital gain or loss if you have held your Notes for more than one year (otherwise such gain or loss should be short-term capital gain or loss if held
        for one year or less).The deductibility of capital losses is subject to limitations.</div>
      <div style="text-align: justify; margin-top: 10pt; font-weight: bold;">Based on certain factual representations received from us, our special U.S. tax counsel, Fried, Frank, Harris, Shriver &amp; Jacobson LLP, is of the opinion that it would be
        reasonable to treat your Notes in the manner described above. However, because there is no authority that specifically addresses the tax treatment of the Notes, it is possible that your Notes could alternatively be treated for tax purposes as a
        single contingent payment debt instrument, or pursuant to some other characterization, (including with regard to the Equity Reference Asset, possible treatment as a &#8220;constructive ownership transaction&#8221; under Section 1260 of the Code) such that the
        timing and character of your income from the Notes could differ materially and adversely from the treatment described above, as described further under &#8220;Material U.S. Federal Income Tax Consequences &#8212; Alternative Treatments&#8221; in the product
        supplements.</div>
      <div style="text-align: justify; margin-top: 10pt;"><font style="font-style: italic;">Section 1260</font>. Because the Equity Reference Asset would be treated as a &#8220;pass-thru entity&#8221; for purposes of Section 1260 of the Code, it is possible that an
        investment in the Notes could be treated as a &#8220;constructive ownership transaction&#8221; within the meaning of Section 1260 of the Code. If the Notes were treated as a constructive ownership transaction certain adverse U.S. federal income tax
        consequences could apply (i.e., all or a portion of any long-term capital gain that you recognize upon the taxable disposition of your Notes could be recharacterized as ordinary income and you could be subject to an interest charge on deferred tax
        liability with respect to such recharacterized gain). We urge you to read the discussion concerning the possible treatment of the Notes as a constructive ownership transaction under &#8220;Material U.S. Federal Income Tax Consequences &#8211; Section 1260&#8221; in
        the product supplement MLN-ES-ETF-1.</div>
      <div style="text-align: justify; margin-top: 10pt;">Except to the extent otherwise required by law, TD intends to treat your Notes for U.S. federal income tax purposes in accordance with the treatment described above and under &#8220;Material U.S. Federal
        Income Tax Consequences&#8221; of the applicable product supplement, unless and until such time as the Treasury and the IRS determine that some other treatment is more appropriate.</div>
      <div style="text-align: justify; margin-top: 10pt;"><font style="font-style: italic;">Section 1297</font>. We will not attempt to ascertain whether any of the Reference Asset Constituent Issuers would be treated as a &#8220;passive foreign investment
        company&#8221; (&#8220;PFIC&#8221;) within the meaning of Section 1297 of the Code. If any such entity were so treated, certain adverse U.S. federal income tax consequences might apply upon the taxable disposition of a Note. You should refer to information filed
        with the SEC or the equivalent governmental authority by such entities and consult your tax advisor regarding the possible consequences to you if any such entity is or becomes a PFIC.</div>
      <div style="text-align: justify; margin-top: 10pt;"><font style="font-style: italic;">Notice 2008-2. </font>In 2007, the IRS released a notice that may affect the taxation of holders of the Notes. According to Notice 2008-2, the IRS and the Treasury
        are considering whether a holder of an instrument such as the Notes should be required to accrue ordinary income on a current basis. It is not possible to determine what guidance they will ultimately issue, if any. It is possible, however, that
        under such guidance, holders of the Notes will ultimately be required to accrue income currently and this could be applied on a retroactive basis. According to the Notice, the IRS and the Treasury are also considering other relevant issues,
        including whether additional gain or loss from such instruments should be treated as ordinary or capital, whether non-U.S. holders of such instruments should be subject to withholding tax on any deemed income accruals, and whether the special
        &#8220;constructive ownership rules&#8221; of Section 1260 of the Code (discussed above) should be applied to such instruments. Both U.S. and non-U.S. holders are urged to consult their tax advisors concerning the significance, and the potential impact, of the
        above considerations on their investments in the Notes.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <div>
            <div>
              <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

                  <tr>
                    <td style="width: 50.00%;">
                      <div style="font-size: 8pt; text-align: left;">TD SECURITIES (USA) LLC</div>
                    </td>
                    <td style="width: 50.00%;">
                      <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">19</font></div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify;"><font style="font-style: italic;">Medicare Tax on Net Investment Income</font>. U.S. holders that are individuals, estates or certain trusts are subject to an additional 3.8% tax on all or a portion of their &#8220;net
        investment income&#8221; or &#8220;undistributed net investment income&#8221; in the case of an estate or trust, which may include any income or gain realized with respect to the Notes, to the extent of their net investment income or undistributed net investment
        income (as the case may be) that, when added to their other modified adjusted gross income, exceeds $200,000 for an unmarried individual, $250,000 for a married taxpayer filing a joint return (or a surviving spouse), $125,000 for a married
        individual filing a separate return or the dollar amount at which the highest tax bracket begins for an estate or trust. The 3.8% Medicare tax is determined in a different manner than the regular income tax. U.S. holders should consult their tax
        advisors as to the consequences of the 3.8% Medicare tax.</div>
      <div style="text-align: justify; margin-top: 10pt;"><font style="font-style: italic;">Specified Foreign Financial Assets. </font>Certain<font style="font-style: italic;">&#160;</font>U.S. holders that own &#8220;specified foreign financial assets&#8221; in excess of
        an applicable threshold may be subject to reporting obligations with respect to such assets with their tax returns, especially if such assets are held outside the custody of a U.S. financial institution. U.S. holders are urged to consult their tax
        advisors as to the application of this legislation to their ownership of the Notes.</div>
      <div style="text-align: justify; margin-top: 10pt;"><font style="font-style: italic;">Backup Withholding and Information Reporting</font>. The proceeds received from a taxable disposition of the Notes will be subject to information reporting unless
        you are an &#8220;exempt recipient&#8221; and may also be subject to backup withholding at the rate specified in the Code if you fail to provide certain identifying information (such as an accurate taxpayer number, if you are a U.S. holder) or meet certain
        other conditions.</div>
      <div style="text-align: justify; margin-top: 10pt;"><font style="font-style: italic;">Non-U.S. Holders.</font> If you are a non-U.S. holder, subject to Section 871(m) of the Code and FATCA, as discussed below, you should generally not be subject to
        U.S. withholding tax with respect to payments on your Notes or to generally applicable information reporting and backup withholding requirements with respect to payments on your Notes if you comply with certain certification and identification
        requirements as to your non-U.S. status including providing us (and/or the applicable withholding agent) a properly executed and fully completed applicable IRS Form W-8. Subject to Section 897 of the Code and Section 871(m) of the Code, as
        discussed below, gain realized from the taxable disposition of the Notes generally should not be subject to U.S. tax unless (i) such gain is effectively connected with a trade or business conducted by you in the U.S., (ii) you are a non-resident
        alien individual and are present in the U.S. for 183 days or more during the taxable year of such taxable disposition and certain other conditions are satisfied or (iii) you have certain other present or former connections with the U.S.</div>
      <div style="text-align: justify; margin-top: 10pt;"><font style="font-style: italic;">Section 897.</font> We will not attempt to ascertain whether any Reference Asset Constituent Issuer or, with respect to the Equity Reference Asset, whether the
        issuer of the Reference Asset, would be treated as a &#8220;United States real property holding corporation&#8221; (a &#8220;USRPHC&#8221;) within the meaning of Section 897 of the Code. We also have not attempted to determine whether the Notes should be treated as
        &#8220;United States real property interests&#8221; (&#8220;USRPI&#8221;) as defined in Section 897 of the Code. If any such entity and the Notes were so treated, certain adverse U.S. federal income tax consequences could possibly apply, including subjecting any gain to a
        non-U.S. holder in respect of a Note upon a taxable disposition of the Note to U.S. federal income tax on a net basis, and the proceeds from such a taxable disposition to a 15% withholding tax. Non-U.S. holders should consult their tax advisors
        regarding the potential treatment of any such entity as a USRPHC and the Notes as USRPI.</div>
      <div style="text-align: justify; margin-top: 10pt;"><font style="font-style: italic;">Section 871(m).</font> A 30% withholding tax (which may be reduced by an applicable income tax treaty) is imposed under Section 871(m) of the Code on certain
        &#8220;dividend equivalents&#8221; paid or deemed paid to a non-U.S. holder with respect to a &#8220;specified equity-linked instrument&#8221; that references one or more dividend-paying U.S. equity securities or indices containing U.S. equity securities. The withholding
        tax can apply even if the instrument does not provide for payments that reference dividends. Treasury regulations provide that the withholding tax applies to all dividend equivalents paid or deemed paid on specified equity-linked instruments that
        have a delta of one (&#8220;delta-one specified equity-linked instruments&#8221;) issued after 2016 and to all dividend equivalents paid or deemed paid on all other specified equity-linked instruments issued after 2017. However, the IRS has issued guidance
        that states that the Treasury and the IRS intend to amend the effective dates of the Treasury regulations to provide that withholding on dividend equivalents paid or deemed paid will not apply to specified equity-linked instruments that are not
        delta-one specified equity-linked instruments and are issued before January 1, 2027.</div>
      <div style="text-align: justify; margin-top: 10pt;">Based on our determination that the Notes are not &#8220;delta-one&#8221; with respect to the Reference Assets or any Reference Asset Constituent, our special U.S. tax counsel is of the opinion that the Notes
        should not be delta-one specified equity-linked instruments and thus should not be subject to withholding on dividend equivalents. Our determination is not binding on the IRS, and the IRS may disagree with this determination. Furthermore, the
        application of Section 871(m) of the Code will depend on our determinations on the date the terms of the Notes are set. If withholding is required, we will not make payments of any additional amounts.</div>
      <div style="text-align: justify; margin-top: 10pt;">Nevertheless, after the date the terms are set, it is possible that your Notes could be deemed to be reissued for tax purposes upon the occurrence of certain events affecting any Reference Asset,
        any Reference Asset Constituent or your Notes, and following such occurrence your Notes could be treated as delta-one specified equity-linked instruments that are subject to withholding on dividend equivalents. It is also possible that withholding
        tax or other tax under Section 871(m) of the Code could apply to the Notes under these rules if you enter, or have entered, into certain other transactions in respect of any Reference Asset, any Reference Asset Constituent or the Notes. If you
        enter, or have entered, into other transactions in respect of any Reference Asset, any Reference Asset Constituent or the Notes, you should consult your tax advisor regarding the application of Section 871(m) of the Code to your Notes in the
        context of your other transactions.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <div>
            <div>
              <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

                  <tr>
                    <td style="width: 50.00%;">
                      <div style="font-size: 8pt; text-align: left;">TD SECURITIES (USA) LLC</div>
                    </td>
                    <td style="width: 50.00%;">
                      <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">20</font></div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; font-weight: bold;">Because of the uncertainty regarding the application of the 30% withholding tax on dividend equivalents to the Notes, you are urged to consult your tax advisor regarding the potential application
        of Section 871(m) of the Code and the 30% withholding tax to an investment in the Notes.</div>
      <div style="text-align: justify; margin-top: 10pt;"><font style="font-style: italic;">U.S. Federal Estate Tax Treatment of Non-U.S. Holders</font>. A Note may be subject to U.S. federal estate tax if an individual non-U.S. holder holds the Note at
        the time of his or her death. The gross estate of a non-U.S. holder domiciled outside the U.S. includes only property situated in the U.S. Individual non-U.S. holders should consult their tax advisors regarding the U.S. federal estate tax
        consequences of holding the Notes at death.</div>
      <div style="text-align: justify; margin-top: 10pt;"><font style="font-style: italic;">Foreign Account Tax Compliance Act. </font>The Foreign Account Tax Compliance Act (&#8220;FATCA&#8221;) was enacted on March 18, 2010, and imposes a 30% U.S. withholding tax
        on &#8220;withholdable payments&#8221; (i.e., certain U.S.-source payments, including interest (and original issue discount), dividends, other fixed or determinable annual or periodical income, and the gross proceeds from a disposition of property of a type
        that can produce U.S.-source interest or dividends) and &#8220;passthru payments&#8221; (i.e., certain payments attributable to withholdable payments) made to certain foreign financial institutions (and certain of their affiliates) unless the payee foreign
        financial institution agrees (or is required), among other things, to disclose the identity of any U.S. individual with an account at the institution (or the relevant affiliate) and to annually report certain information about such account. FATCA
        also requires withholding agents making withholdable payments to certain foreign entities that do not disclose the name, address, and taxpayer identification number of any substantial U.S. owners (or do not certify that they do not have any
        substantial U.S. owners) to withhold tax at a rate of 30%. Under certain circumstances, a holder may be eligible for refunds or credits of such taxes.</div>
      <div style="text-align: justify; margin-top: 10pt;">Pursuant to final and temporary Treasury regulations and other IRS guidance, the withholding and reporting requirements under FATCA will generally apply to certain &#8220;withholdable payments&#8221;, will not
        apply to gross proceeds on a sale or disposition, and will apply to certain foreign passthru payments only to the extent that such payments are made after the date that is two years after final regulations defining the term &#8220;foreign passthru
        payment&#8221; are published. If withholding is required, we (or the applicable paying agent) will not be required to pay additional amounts with respect to the amounts so withheld. Foreign financial institutions and non-financial foreign entities
        located in jurisdictions that have an intergovernmental agreement with the U.S. governing FATCA may be subject to different rules.</div>
      <div style="text-align: justify; margin-top: 10pt; margin-bottom: 6pt;">Investors should consult their tax advisors about the application of FATCA, in particular if they may be classified as financial institutions (or if they hold their Notes through
        a foreign entity) under the FATCA rules.</div>
      <div style="text-align: justify; margin-top: 10pt; margin-bottom: 6pt;"><font style="font-style: italic;">Proposed Legislation.</font> In 2007, legislation was introduced in Congress that, if it had been enacted, would have required holders of Notes
        purchased after the bill was enacted to accrue interest income over the term of the Notes despite the fact that there will be no interest payments over the term of the Notes.</div>
      <div style="text-align: justify; margin-top: 10pt; margin-bottom: 6pt;">Furthermore, in 2013, the House Ways and Means Committee released in draft form certain proposed legislation relating to financial instruments. If it had been enacted, the effect
        of this legislation generally would have been to require instruments such as the Notes to be marked to market on an annual basis with all gains and losses to be treated as ordinary, subject to certain exceptions.</div>
      <div style="text-align: justify; margin-top: 10pt;">It is impossible to predict whether any similar or identical bills will be enacted in the future, or whether any such bill would affect the tax treatment of your Notes. You are urged to consult your
        tax advisor regarding the possible changes in law and their possible impact on the tax treatment of your Notes.</div>
      <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">Both U.S. and non-U.S. holders are urged to consult their tax advisors concerning the application of U.S. federal income tax laws to an investment in the Notes, as well as any tax
        consequences of the purchase, beneficial ownership and disposition of the Notes arising under the laws of any state, local, non-U.S. or other taxing jurisdiction (including that of TD and those of the Reference Asset Constituent Issuers).</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <div>
            <div>
              <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

                  <tr>
                    <td style="width: 50.00%;">
                      <div style="font-size: 8pt; text-align: left;">TD SECURITIES (USA) LLC</div>
                    </td>
                    <td style="width: 50.00%;">
                      <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">21</font></div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-bottom: 10pt; color: rgb(0, 176, 80); font-size: 16pt;">Supplemental Plan of Distribution (Conflicts of Interest)</div>
      <div style="text-align: justify; margin-bottom: 10pt;">We have appointed TDS, an affiliate of TD, as the Agent for the sale of the Notes. Pursuant to the terms of a distribution agreement, TDS will purchase the Notes from TD at the public offering
        price less an underwriting discount of up to the underwriting discount specified on the cover page hereof and may use all or a portion of that commission to allow selling concessions to other registered broker-dealers in connection with the
        distribution of the Notes. The total &#8220;Underwriting Discount&#8221; and &#8220;Proceeds to TD&#8221; to be specified on the cover hereof will reflect the aggregate of the underwriting discount at the time TD established any hedge positions on or prior to the Pricing
        Date, which may be variable and fluctuate depending on market conditions at such times. The Notes will generally be offered to the public at the public offering price, provided that certain fee based advisory accounts may purchase the Notes for as
        low as the price specified on the cover hereof and such registered broker-dealers may forgo, in their sole discretion, some or all of their selling concessions in connection with such sales. We or one of our affiliates may also pay a fee to
        iCapital Markets LLC, who is acting as a dealer in connection with the distribution of the Notes. TD will reimburse TDS for certain expenses in connection with its role in the offer and sale of the Notes, and TD will pay TDS a fee in connection
        with its role in the offer and sale of the Notes.</div>
      <div style="text-align: justify; margin-bottom: 10pt;"><font style="font-style: italic;">Conflicts of Interest. </font>TDS is an affiliate of TD and, as such, has a &#8220;conflict of interest&#8221; in this offering within the meaning of Financial Industry
        Regulatory Authority, Inc. (&#8220;FINRA&#8221;) Rule 5121. If any other affiliate of TD participates in this offering, that affiliate will also have a &#8220;conflict of interest&#8221; within the meaning of FINRA Rule 5121. In addition, TD will receive the net proceeds
        from the initial public offering of the Notes, thus creating an additional conflict of interest within the meaning of FINRA Rule 5121. This offering of the Notes will be conducted in compliance with the provisions of FINRA Rule 5121. In accordance
        with FINRA Rule 5121, neither TDS nor any other affiliate of ours is permitted to sell the Notes in this offering to an account over which it exercises discretionary authority without the prior specific written approval of the account holder.</div>
      <div style="text-align: justify; margin-bottom: 10pt;">We, TDS, another of our affiliates or third parties may use this pricing supplement in the initial sale of the Notes. In addition, we, TDS, another of our affiliates or third parties may use this
        pricing supplement in a market-making transaction in the Notes after their initial sale. <font style="font-weight: bold; font-style: italic;">If a purchaser buys the Notes from us, TDS, another of our affiliates or third parties, this pricing
          supplement is being used in a market-making transaction unless we, TDS, another of our affiliates or third parties informs such purchaser otherwise in the confirmation of sale.</font></div>
      <div style="text-align: justify; margin-bottom: 10pt; font-weight: bold;">Prohibition on Sales to EEA Retail Investors</div>
      <div style="text-align: justify; margin-bottom: 10pt;">The Notes are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to any retail investor in the European Economic Area (the
        &#8220;EEA&#8221;). For these purposes, a retail investor means a person who is one (or more) of: (i) a retail client as defined in point (11) of Article 4(1) of Directive 2014/65/EU (as amended, &#8220;MiFID II&#8221;); (ii) a customer within the meaning of Directive
        (EU) 2016/97, where that customer would not qualify as a professional client as defined in point (10) of Article 4(1) of MiFID II; or (iii) not a qualified investor as defined in Regulation (EU) 2017/1129, as amended. Consequently no key
        information document required by Regulation (EU) No 1286/2014 (the &#8220;EU PRIIPs Regulation&#8221;) for offering or selling the Notes or otherwise making them available to retail investors in the EEA has been prepared and therefore offering or selling the
        Notes or otherwise making them available to any retail investor in the EEA may be unlawful under the EU PRIIPs Regulation.</div>
      <div style="text-align: justify; margin-bottom: 10pt; font-weight: bold;">Prohibition on Sales to United Kingdom Retail Investors</div>
      <div style="text-align: justify;">The Notes are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to any retail investor in the United Kingdom (&#8220;UK&#8221;). For these purposes, a
        retail investor means a person who is one (or more) of: (i) a retail client, as defined in point (8) of Article 2 of Regulation (EU) No 2017/565 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018 (the &#8220;EUWA&#8221;); or
        (ii) a customer within the meaning of the provisions of the Financial Services and Markets Act 2000 (the &#8220;FSMA&#8221;) and any rules or regulations made under the FSMA to implement Directive (EU) 2016/97, where that customer would not qualify as a
        professional client, as defined in point (8) of Article 2(1) of Regulation (EU) No 600/2014 as it forms part of domestic law by virtue of the EUWA. Consequently no key information document required by Regulation (EU) No 1286/2014 as it forms part
        of domestic law by virtue of the EUWA (the &#8220;UK PRIIPs Regulation&#8221;) for offering or selling the Notes or otherwise making them available to retail investors in the UK has been prepared and therefore offering or selling the Notes or otherwise making
        them available to any retail investor in the UK may be unlawful under the UK PRIIPs Regulation.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <div>
            <div>
              <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

                  <tr>
                    <td style="width: 50.00%;">
                      <div style="font-size: 8pt; text-align: left;">TD SECURITIES (USA) LLC</div>
                    </td>
                    <td style="width: 50.00%;">
                      <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">22</font></div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-bottom: 8pt; color: rgb(0, 176, 80); font-size: 16pt;">Additional Information Regarding the Estimated Value of the Notes</div>
      <div style="text-align: justify; margin-bottom: 8pt;">The final terms for the Notes will be determined on the date the Notes are initially priced for sale to the public, which we refer to as the Pricing Date, based on prevailing market conditions,
        and will be communicated to investors in the final pricing supplement.</div>
      <div style="text-align: justify; margin-bottom: 8pt;">The economic terms of the Notes are based on our internal funding rate (which is our internal borrowing rate based on variables such as market benchmarks and our appetite for borrowing), and
        several factors, including any sales commissions expected to be paid to TDS or another affiliate of ours, any selling concessions, discounts, commissions or fees expected to be allowed or paid to non-affiliated intermediaries, the estimated profit
        that we or any of our affiliates expect to earn in connection with structuring the Notes, estimated costs which we may incur in connection with the Notes and the estimated cost which we may incur in hedging our obligations under the Notes. Because
        our internal funding rate generally represents a discount from the levels at which our benchmark debt securities trade in the secondary market, the use of an internal funding rate for the Notes rather than the levels at which our benchmark debt
        securities trade in the secondary market is expected to have an adverse effect on the economic terms of the Notes.</div>
      <div style="text-align: justify; margin-bottom: 8pt;">On the cover page of this pricing supplement, we have provided the estimated value range for the Notes. The estimated value range was determined by reference to our internal pricing models which
        take into account a number of variables and are based on a number of assumptions, which may or may not materialize, typically including volatility, interest rates (forecasted, current and historical rates), price-sensitivity analysis, time to
        maturity of the Notes and our internal funding rate. For more information about the estimated value, see &#8220;Additional Risk Factors &#8212; Risks Relating to Estimated Value and Liquidity&#8221; herein. Because our internal funding rate generally represents a
        discount from the levels at which our benchmark debt securities trade in the secondary market, the use of an internal funding rate for the Notes rather than the levels at which our benchmark debt securities trade in the secondary market is
        expected, assuming all other economic terms are held constant, to increase the estimated value of the Notes. For more information see the discussion under &#8220;Additional Risk Factors &#8212; Risks Relating to Estimated Value and Liquidity &#8212; The Estimated
        Value of Your Notes Is Based on Our Internal Funding Rate.&#8221;</div>
      <div style="text-align: justify; margin-bottom: 8pt;">Our estimated value on the Pricing Date is not a prediction of the price at which the Notes may trade in the secondary market, nor will it be the price at which the Agent may buy or sell the Notes
        in the secondary market. Subject to normal market and funding conditions, the Agent or another affiliate of ours intends to offer to purchase the Notes in the secondary market but it is not obligated to do so.</div>
      <div style="text-align: justify; margin-bottom: 8pt;">Assuming that all relevant factors remain constant after the Pricing Date, the price at which the Agent may initially buy or sell the Notes in the secondary market, if any, may exceed our
        estimated value on the Pricing Date for a temporary period expected to be approximately 3 months after the Issue Date because, in our discretion, we may elect to effectively reimburse to investors a portion of the estimated cost of hedging our
        obligations under the Notes and other costs in connection with the Notes which we will no longer expect to incur over the term of the Notes. We made such discretionary election and determined this temporary reimbursement period on the basis of a
        number of factors, including the tenor of the Notes and any agreement we may have with the distributors of the Notes. The amount of our estimated costs which we effectively reimburse to investors in this way may not be allocated ratably throughout
        the reimbursement period, and we may discontinue such reimbursement at any time or revise the duration of the reimbursement period after the Issue Date of the Notes based on changes in market conditions and other factors that cannot be predicted.</div>
      <div style="font-weight: bold; text-align: justify;">We urge you to read the &#8220;Additional Risk Factors&#8221; herein.</div>
      <div>
        <div><br>
        </div>
        <br>
        <div class="BRPFPageFooter" style="width: 100%;">
          <div>
            <div>
              <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

                  <tr>
                    <td style="width: 50.00%;">
                      <div style="font-size: 8pt; text-align: left;">TD SECURITIES (USA) LLC</div>
                    </td>
                    <td style="width: 50.00%;">
                      <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">23</font></div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image0.jpg
<TEXT>
begin 644 image0.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !) %$# 2(  A$! Q$!_\0
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MVO/^C5OVD/\ PQWQ._\ F7KL_L+//^A-FO\ X;L7_P#*3U_]2.-/^B0XH_\
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M_%.'_J\O_G//_P >3_-_HK_2 HH_XEG_ .JV_P#-;_\ P\'_ !3A_P"KR_\
(G//_ ,>3_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image00001.jpg
<TEXT>
begin 644 image00001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" %  @0# 2(  A$! Q$!_\0
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M#_P F_\ B:Z.B@#G/^$RTK^[J'_@!-_\31_PF6E?W=0_\ )O_B:Z.B@#G/\
MA,M*_NZA_P" $W_Q-'_"9:5_=U#_ , )O_B:Z.B@#G/^$RTK^[J'_@!-_P#$
MT?\ "9:5_=U#_P  )O\ XFNCHH YS_A,M*_NZA_X 3?_ !-'_"9:5_=U#_P
MF_\ B:Z.B@#G/^$RTK^[J'_@!-_\31_PF6E?W=0_\ )O_B:Z.B@#G/\ A,M*
M_NZA_P" $W_Q-'_"9:5_=U#_ , )O_B:Z.B@#G/^$RTK^[J'_@!-_P#$T?\
M"9:5_=U#_P  )O\ XFNCHH YS_A,M*_NZA_X 3?_ !-'_"9:5_=U#_P F_\
MB:Z.B@#G/^$RTK^[J'_@!-_\31_PF6E?W=0_\ )O_B:Z.B@#G/\ A,M*_NZA
M_P" $W_Q-6-.\3:;J-\EG URMPZLR+-;21;@.N"P&<5MUSFL?\CMX=_ZXW?\
MHZ .CHHHH **** "N*^)_3PG_P!C!:?^S5VM<5\3^GA/_L8+3_V:@#M:***
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M_H(>'_\ P!F_^/4>1XQ_Z"'A_P#\ 9O_ (]72T4 <UY'C'_H(>'_ /P!F_\
MCU'D>,?^@AX?_P# &;_X]72T4 <UY'C'_H(>'_\ P!F_^/4>1XQ_Z"'A_P#\
M 9O_ (]72T4 <UY'C'_H(>'_ /P!F_\ CU'D>,?^@AX?_P# &;_X]72T4 <U
MY'C'_H(>'_\ P!F_^/4>1XQ_Z"'A_P#\ 9O_ (]72T4 <UY'C'_H(>'_ /P!
MF_\ CU'D>,?^@AX?_P# &;_X]72T4 <UY'C'_H(>'_\ P!F_^/4>1XQ_Z"'A
M_P#\ 9O_ (]72T4 <UY'C'_H(>'_ /P!F_\ CU'D>,?^@AX?_P# &;_X]72T
M4 <UY'C'_H(>'_\ P!F_^/4>1XQ_Z"'A_P#\ 9O_ (]72T4 <UY'C'_H(>'_
M /P!F_\ CU'D>,?^@AX?_P# &;_X]72T4 <UY'C'_H(>'_\ P!F_^/4>1XQ_
MZ"'A_P#\ 9O_ (]72T4 <UY'C'_H(>'_ /P!F_\ CU'D>,?^@AX?_P# &;_X
M]72T4 <UY'C'_H(>'_\ P!F_^/4>1XQ_Z"'A_P#\ 9O_ (]72T4 <UY'C'_H
M(>'_ /P!F_\ CU'D>,?^@AX?_P# &;_X]72T4 <UY'C'_H(>'_\ P!F_^/4>
M1XQ_Z"'A_P#\ 9O_ (]72T4 <UY'C'_H(>'_ /P!F_\ CU'D>,?^@AX?_P#
M&;_X]72T4 <UY'C'_H(>'_\ P!F_^/4>1XQ_Z"'A_P#\ 9O_ (]72T4 <UY'
MC'_H(>'_ /P!F_\ CU'D>,?^@AX?_P# &;_X]72T4 <UY'C'_H(>'_\ P!F_
M^/4>1XQ_Z"'A_P#\ 9O_ (]72T4 <UY'C'_H(>'_ /P!F_\ CU'D>,?^@AX?
M_P# &;_X]72T4 <UY'C'_H(>'_\ P!F_^/4>1XQ_Z"'A_P#\ 9O_ (]72T4
M<UY'C'_H(>'_ /P!F_\ CU'D>,?^@AX?_P# &;_X]72T4 <UY'C'_H(>'_\
MP!F_^/4>1XQ_Z"'A_P#\ 9O_ (]72T4 <UY'C'_H(>'_ /P!F_\ CU'D>,?^
M@AX?_P# &;_X]72T4 <UY'C'_H(>'_\ P!F_^/5G!-83QMH?]M7&GS?N;GRO
MLD#Q8X3.=SMGMTQWKMJY#5M2M3\3= TP2_Z<EE<W+1X/$9*J&_-2/PII-[ =
M?10**D HHHI@%<5\3^GA/_L8+3_V:NUKBOB?T\)_]C!:?^S4 =K1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH ***X3QA\2=,\+^-?#GARZ3S+C6)#&760?Z-D@(67&3N8X'3H350A*H[
M15P.[HKGO&'C#1/!]I#<>(;^.SCG9DBW G>P4L1Q[#^7K6!X ^*NA>,?"VI:
MW'YEA'I@)O8KG&Z%=NX-QU! .#W(-4J-1QYTM!75['H%%<K\._'6D^/]#?5-
M"\\01SM;R).FUU8 'H"1R"#U[UU53.+A)QDK-#"BBBI **** "BBB@ HHHH
M**** "BBB@ HI.:\T\._&'1?$'Q D\)Z=:7OVN%KA)II5544PG!QR20<'TZ5
M<*<IIN*VW%='IF:J0:A:3W]S90W$3W=LJ-/"K9:,/G:2.V<''TKR?XB?%(R_
M!H^*_!$I6:XN4M86GB^=6W[6 4]3P?6O-O ?Q"UD_%#_ (3.^LG@\,>)+J/1
MS),=JQLBKL(QP<$D!CZM753P-2<)3VM^:Z"<D?5E0W5Q%:6\MQ<R+%!"ADDD
M8X"J!DD^P%2]Z\Q_:"\57'AWP0UGI^GMJ%]K9DTV*%22P#QMN8*.6P.P]17+
M1INK-074;=E<V-9^(.CCX>:UXGT6_@NK>SCF2.3DJTZ\*N.^6V_4'BN2\/\
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M#CI7S_YGQ&^+5QI.GZUIS>'/"MR@O7O+%B)&7:2B[F).22., 5SGQ$^&ESX
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M<^'_ /G\F_\  .;_ .(K,9TU%<S_ ,)SX?\ ^?R;_P  YO\ XBC_ (3GP_\
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MA2WBCB0L7*HH4%B<D\=R:DKF?^$Y\/\ _/Y-_P" <W_Q%'_"<^'_ /G\F_\
M .;_ .(KD*.F-8WBSPYIOBK0KK2-9A\VRN5 < X88(((/8Y%4O\ A.?#_P#S
M]S?^ <W_ ,11_P )SX?_ .?N;_P#F_\ B*$W%W0'065M#9V<%K;1K'! BQQH
MO1548 'T J:N9_X3GP__ ,_<W_@'-_\ $4?\)SX?_P"?R;_P#F_^(H Z:BN9
M_P"$Y\/_ //Y-_X!S?\ Q%'_  G/A_\ Y_)O_ .;_P"(H Z:BN9_X3GP_P#\
M_DW_ (!S?_$4?\)SX?\ ^?R;_P  YO\ XB@#IJ*YG_A.?#__ #^3?^ <W_Q%
M'_"<^'_^?R;_ , YO_B* .FHKF?^$Y\/_P#/Y-_X!S?_ !%'_"<^'_\ G\F_
M\ YO_B* .FKG-8_Y';P[_P!<;O\ E'3/^$Y\/_\ /Y-_X!S?_$5GKKFGZUXV
MT/\ LZ9Y?)AN=^Z%X\9"8^\!GH>E ';4444 %9VKZ1#J:Q^9+/!)'G9+ ^UP
M",,,\\$5HT4 8VF^'+'3;M)K42JD8(B@+YCAS]XJ.Q/?DUA_$[A?"N>^OVG_
M +-7:UQ7Q/Z>$_\ L8+3_P!FH3L!1^*/PRLO&VAZA:VLZ:7?7\\$US>"(RF3
MR050%=PZ!B.M5?V?X)-,\%7?A^XE>:XT+4KG3Y)#T;#;U(]MLB\=J]-KY$^)
M7B#Q)\.?C5K5UH<E])IC2KJ#6KN5@DDGBV!F QN <8'^YBN_"QGB8/#W\UZD
M2M'4Z7XH?%L>*=<OOASI=EY4.H7::4=3\_(WF5%)"@?=Z@\D\UY[XFM?B#H6
MD7$%PVIVFC>#[F.2P$L64D!G)B=CT;:-N.H XXKWGX:_#*VD\&Z)/XJLY8-;
MCU5]>DC5RGEW+-D CG@!5&/:NQ^+6E+K/PS\36+1/*SV$KQQH>6D1=Z?^/*M
M=$,72HRC2IQTZ]==FU\@Y6]6>5^(/$6N?$B[T#PCH(OEL0(6\1:DB-$JD)&[
M(D@[G)R,=2O:N6M_@5XT\*>()]4\*:H+B[M7@DM)WE$7VAB<R^8I)^4>A/(/
M>O4/V8]"?1OA59SSS^=+JLK:@2"3M#*JJ.>^U!FO6L"LIXN6'E*E1MR[>H*-
MU=GS!KGQ,U?X@2Z/X3TN1M*\76FIR>=Y63#.\$;LI5CC"M(@!4]CGFO2OA9\
M++31U77_ !3:0WGBVZ=I[EY<3)!(9"ZB/.=I7@;@>U>FPZ?9PW<UU#:P)=3;
M1+,L8#R;>!N;&3C)QFK.*PJ8J\>2DN5?U^'D-1ZL3'O2T45R%!1110 4444
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M!Z'17._:_%O_ $!=!_\ !Q-_\BT?:_%O_0$T'_P<3?\ R+0!T5%<[]K\6_\
M0$T'_P '$W_R+1]K\6_] 30?_!Q-_P#(M '145SOVOQ;_P! 30?_  <3?_(M
M'VOQ;_T!-!_\'$W_ ,BT =%17._:_%O_ $!-!_\ !Q-_\BT?:_%O_0$T'_P<
M3?\ R+0!T5%<[]K\6_\ 0$T'_P '$W_R+1]K\6_] 30?_!Q-_P#(M '145SO
MVOQ;_P! 30?_  <3?_(M'VOQ;_T!-!_\'$W_ ,BT =%17._:_%O_ $!-!_\
M!Q-_\BT?:_%O_0$T'_P<3?\ R+0!T5%<[]K\6_\ 0$T'_P '$W_R+1]K\6_]
M 30?_!Q-_P#(M '145SOVOQ;_P! 30?_  <3?_(M'VOQ;_T!-!_\'$W_ ,BT
M =%17._:_%O_ $!-!_\ !Q-_\BT?:_%O_0$T'_P<3?\ R+0!T5%<[]K\6_\
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M)[XKB_B?T\)_]C!:?^S5VM<5\3^GA/\ [&"T_P#9J .UHHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "N<UC_ )';P[_UQN_Y1UT=<YK'_([>'?\ KC=_RCH
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M (B@#IJ*YG_A%'_Z&+Q#_P"!2_\ Q%'_  BC_P#0Q>(?_ I?_B* .FHKF?\
MA%'_ .AB\0_^!2__ !%'_"*/_P!#%XA_\"E_^(H Z:BN9_X11_\ H8O$/_@4
MO_Q%'_"*/_T,7B'_ ,"E_P#B* .FHKF?^$4?_H8O$/\ X%+_ /$4?\(H_P#T
M,7B'_P "E_\ B* .FHKF?^$4?_H8O$/_ (%+_P#$4?\ "*/_ -#%XA_\"E_^
M(H Z:BN9_P"$4?\ Z&+Q#_X%+_\ $4?\(H__ $,7B'_P*7_XB@#IJ*YG_A%'
M_P"AB\0_^!2__$4?\(H__0Q>(?\ P*7_ .(H Z:BN9_X11_^AB\0_P#@4O\
M\11_PBC_ /0Q>(?_  *7_P"(H Z:BN9_X11_^AB\0_\ @4O_ ,11_P (H_\
MT,7B'_P*7_XB@#IJ*YG_ (11_P#H8O$/_@4O_P 11_PBC_\ 0Q>(?_ I?_B*
M .FHKF?^$4?_ *&+Q#_X%+_\11_PBC_]#%XA_P# I?\ XB@#IJ*YG_A%'_Z&
M+Q#_ .!2_P#Q%'_"*/\ ]#%XA_\  I?_ (B@#IJ*YG_A%'_Z&+Q#_P"!2_\
MQ%'_  BC_P#0Q>(?_ I?_B* .FHKF?\ A%'_ .AB\0_^!2__ !%'_"*/_P!#
M%XA_\"E_^(H Z:BN9_X11_\ H8O$/_@4O_Q%'_"*/_T,7B'_ ,"E_P#B* .F
MHKF?^$4?_H8O$/\ X%+_ /$4?\(H_P#T,7B'_P "E_\ B* .FHKF?^$4?_H8
MO$/_ (%+_P#$4?\ "*/_ -#%XA_\"E_^(H Z:BN9_P"$4?\ Z&+Q#_X%+_\
M$4?\(H__ $,7B'_P*7_XB@#IJ*YG_A%'_P"AB\0_^!2__$4?\(H__0Q>(?\
MP*7_ .(H Z:BN9_X11_^AB\0_P#@4O\ \11_PBC_ /0Q>(?_  *7_P"(H Z:
MBN9_X11_^AB\0_\ @4O_ ,11_P (H_\ T,7B'_P*7_XB@#IJYS6/^1V\._\
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M0O\ P81?_%5>_P"$>T7_ * ^G?\ @*G^%'_".Z+_ - ?3O\ P%3_  H H_\
M"<>$_P#H9]"_\&$7_P 51_PG'A/_ *&?0O\ P81?_%5>_P"$=T7_ * ^G?\
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M^$=T7_H#Z=_X"I_A0!1_X3CPG_T,^A?^#"+_ .*H_P"$X\)_]#/H7_@PB_\
MBJO?\([HO_0'T[_P%3_"C_A'=%_Z ^G?^ J?X4 4?^$X\)_]#/H7_@PB_P#B
MJ/\ A./"G_0SZ%_X,(O_ (JKQ\/:+_T!]._\!D_PJC)X0T-]8@U#^S;,/#!)
M;^4+=-C!V1B2,=1Y8Q]30 ?\)QX3_P"AGT+_ ,&$7_Q5'_"<>$_^AGT+_P &
M$7_Q57O^$>T7_H#Z=_X"I_A1_P ([HO_ $!]._\  5/\* */_"<>$_\ H9]"
M_P#!A%_\51_PG'A/_H9]"_\ !A%_\55[_A'=%_Z ^G?^ J?X4?\ ".Z+_P!
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MM+>1?-6,YR^TG) Q^)X%<;::?>+KZZKX=F:XM[Y5=;E(H]KAIMTJSL?F)50
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MSTZ$Q6%K!:Q%BY2&,(I8]3@#K[T 1:+I-GHUBEGIT(B@7G&223ZDGDU>HHH
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F!QDT 1:+I5GHFFPV&FPB&VA4*JY))]R3R3[FKU%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image00002.jpg
<TEXT>
begin 644 image00002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" %# @@# 2(  A$! Q$!_\0
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MEI7]W4/_   F_P#B:/\ A,M*_NZA_P" $W_Q-='10!SG_"9:5_=U#_P F_\
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M=U#_ , )O_B:/^$RTK^[J'_@!-_\371T4 <Y_P )EI7]W4/_   F_P#B:/\
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M=M(0.DB1 ,OX&BN)_9D8S>&=7NF#%KN^DN2[#!D#.Y5C]5V_ABBJJP4)N*Z
MCV:BC-&:S **,T9H XK_ )K2/^Q?_P#;FNUKBO\ FM _[%__ -N:[6@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M:[6@#FO(\8_]!#P__P" ,W_QZCR/&/\ T$/#_P#X S?_ !ZNEHH YKR/&/\
MT$/#_P#X S?_ !ZCR/&/_00\/_\ @#-_\>KI:* .:\CQC_T$/#__ ( S?_'J
M/(\8_P#00\/_ /@#-_\ 'JZ6B@#FO(\8_P#00\/_ /@#-_\ 'J/(\8_]!#P_
M_P" ,W_QZNEHH YKR/&/_00\/_\ @#-_\>H\CQC_ -!#P_\ ^ ,W_P >KI:*
M .:\CQC_ -!#P_\ ^ ,W_P >H\CQC_T$/#__ ( S?_'JZ6B@#FO(\8_]!#P_
M_P" ,W_QZCR/&/\ T$/#_P#X S?_ !ZNEHH YKR/&/\ T$/#_P#X S?_ !ZC
MR/&/_00\/_\ @#-_\>KI:* .:\CQC_T$/#__ ( S?_'J/(\8_P#00\/_ /@#
M-_\ 'JZ6B@#FO(\8_P#00\/_ /@#-_\ 'J/(\8_]!#P__P" ,W_QZNEHH YK
MR/&/_00\/_\ @#-_\>H\CQC_ -!#P_\ ^ ,W_P >KI:* .:\CQC_ -!#P_\
M^ ,W_P >H\CQC_T$/#__ ( S?_'JZ6B@#FO(\8_]!#P__P" ,W_QZCR/&/\
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M/#__ ( S?_'J/(\8_P#00\/_ /@#-_\ 'JZ6B@#FO(\8_P#00\/_ /@#-_\
M'J/(\8_]!#P__P" ,W_QZNEHH YKR/&/_00\/_\ @#-_\>H\CQC_ -!#P_\
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M& 22.,=S15KP_P#\C5XH_P"NUO\ ^B5HH Z.BBB@ HHHH XK_FM(_P"Q?_\
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M*3:1JWV!K4S9B>UAB"S%D/4;@K#'J3U%70H^V=KV!NQZ%\$[2]UK7_%/CW4
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MAH YG_FM(_[%_P#]N:[6N*_YK0/^Q?\ _;FNUH **** "BBB@ HHHH ****
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MYZ:Q_P"#F\_^.UTE% '-_P#"%Z1_STUC_P '-Y_\=H_X0O2/^>FL?^#F\_\
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M#6!E^#.IZ?:\;Y+."//./](B49KT75=-L]6LVM-2MX[FV9U<QR#(+*P93^!
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M\[A1C:-K+C(S@5]$5S/_  G/A_\ Y^YO_ .;_P"(H_X3GP__ ,_DW_@'-_\
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M9B+5-JJ/E7&"%3W^7FO45\;^'USB[F&>>+.;_P"(KTJF95**5*GI9)?/2_\
MD0H)ZL^1C\1=:N[/3_#IBN8]$FT^WT%HW8F(RQ2*#*G&,D  C/0_2OMZ%!'$
MB#HH"C\*^<_C=/X5M_"^A6_AN 0'_A(X;N1([65!E@Q=AN7N0O ].!7M/_"<
M^'QUNYO_  #F_P#B*Y\;5A5A"4(VW_0<4T]3IJ*YG_A.?#__ #^3?^ <W_Q%
M'_"<^'_^?R;_ , YO_B*\\LZ:BN9_P"$Y\/_ //Y-_X!S?\ Q%'_  G/A_\
MY_)O_ .;_P"(H Z:BN9_X3GP_P#\_DW_ (!S?_$4?\)SX?\ ^?R;_P  YO\
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MS["HMM_[I24\LL!UW%/ESGN:O:3I4.F)+Y4DTTDI!>69MSD 8 S@< =*T**
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MS<NY2,_6-'T_6%M!J=JEP+2X2[@#Y^25<[7'N,G\ZOBEHJ+O884444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% '-^'_P#D:O%'_7:W_P#1*T4OA_\ Y&KQ1_UVM_\ T2M% '1T444 %%%%
M '%?\UH'_8O_ /MS7:UQ7_-:1_V+_P#[<UVM "4M%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 <O\4=/DU;X<^)+&%T2
M2>PF56?.!\A/./I7-?LV?\D3\-?[D_\ Z/DKT/5K3[?I=W9[]GVB%X=V,[=R
MD9_6LGP%X;C\(>#M*T&"7SEL81&9=NWS&R2S8R<9))QGO6RJ+V+I^:?X,5M;
MG04445B,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH YSP__P C5XH_Z[6__HE:*/#_ /R-7BC_
M *[6_P#Z)6B@#HL^U&:YKQ_>V%GHH6_N#!+/)Y5KBZ:WW3%3C+!EX RQR<8%
M5]:N+?[#HL=]J@.GE]MW=QW'E!B(25)=2-H)P>HSP.^" =;FC->5Z;J.HM91
MS-=7)U\K()H#(2RPBU+*WE9P/G"G=C)8XSVKKO!DT4DE^EE=-=:>IB\J0SF8
M;RN7 <DGKC(SQ[4 4?\ FM _[%__ -N:[6O,[J?7%^,<IM=.TR20:+MB62_D
M0/%]H^\Q$)VMG'R@$=?F]>J^U^+?^@)H/_@XF_\ D6@#HJ*YW[7XM_Z F@_^
M#B;_ .1:/M?BW_H":#_X.)O_ )%H Z*BN=^U^+?^@)H/_@XF_P#D6C[7XM_Z
M F@_^#B;_P"1: .BHKG?M?BW_H":#_X.)O\ Y%H^U^+?^@)H/_@XF_\ D6@#
MHJ*YW[7XM_Z F@_^#B;_ .1:/M?BW_H":#_X.)O_ )%H Z*BN=^U^+?^@)H/
M_@XF_P#D6C[7XM_Z F@_^#B;_P"1: .BHKG?M?BW_H":#_X.)O\ Y%H^U^+?
M^@)H/_@XF_\ D6@#HJ*YW[7XM_Z F@_^#B;_ .1:/M?BW_H":#_X.)O_ )%H
M Z*BN=^U^+?^@)H/_@XF_P#D6C[7XM_Z F@_^#B;_P"1: .BHKG?M?BW_H":
M#_X.)O\ Y%H^U^+?^@)H/_@XF_\ D6@#HJ*YW[7XM_Z F@_^#B;_ .1:/M?B
MW_H":#_X.)O_ )%H Z*BN=^U^+?^@)H/_@XF_P#D6C[7XM_Z F@_^#B;_P"1
M: .BHKG?M?BW_H":#_X.)O\ Y%H^U^+?^@)H/_@XF_\ D6@#HJ*YW[7XM_Z
MF@_^#B;_ .1:/M?BW_H":#_X.)O_ )%H Z*BN=^U^+?^@)H/_@XF_P#D6C[7
MXM_Z F@_^#B;_P"1: .BHKG?M?BW_H":#_X.)O\ Y%H^U^+?^@)H/_@XF_\
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M** .<\/_ /(U>*/^NUO_ .B5HH\/_P#(U>*/^NUO_P"B5HH Z.BBB@ HHHH
MXK_FM(_[%_\ ]N:[6N*_YK2/^Q?_ /;FNUH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_P"!2_\ Q% '345S/_"*/_T,7B'_ ,"E_P#B*/\ A%'_ .AB\0_^!2__ !%
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M*/\ A%'_ .AB\0_^!2__ !% '345S/\ PBC_ /0Q>(?_  *7_P"(H_X11_\
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M_P"!2_\ Q% '345S/_"*/_T,7B'_ ,"E_P#B*/\ A%'_ .AB\0_^!2__ !%
M#_#_ /R-7BC_ *[6_P#Z)6BJO@VT-EKWB2W-S<7.R:#][</N=LQ \G ]:* .
MMI,<TM% !1110!Q7_-:1_P!B_P#^W-=K7%?\UI'_ &+_ /[<UVM !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 <YX?_ .1J\4?]=K?_ -$K11X?_P"1J\4?
M]=K?_P!$K10!T=%%% !1110!Q7_-:1_V+_\ [<UVM<5_S6D?]B__ .W-=K0
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M6AZ1<)?6 M19O:VA:%[M)/GFMRAQ#*@'+@LIR3VSQD@@#_"=EK=E?00W3/\
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MS(8M/$DSNBPQQP9)41&$+R,JI+ \9)[UVXJ.WACMX(X84"11J$11T4#H*DH
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M;1:9;3R?9Y6; 96(=5C']T;B/08 '3CIA4=O#';PI%"BQQ(H5448"@= *DH
M***#TH 1B%4DG ')/I7+WVIQ:I<V]G+:K<:-=SB!+J.X#+*ZH9,%1P8SM*GG
MD@@C!S2^*YK]LVKP1+I%PT=I)*'/G;I6V!E'3"L5R#U!/ISFVGAR36+H37ZV
M\5H0KROI\^$O)%.!( !\N5W*W.3G&2 #0!I^#K&\TQKJQ,C2:;#CR&:%8U#$
MEF6,#_EF 0!GIC Z5T]-BC2*-(XE5(T 5548  Z "G4 %%%&: $9@JDL0 !D
MDGI7+:EJO]IYT];:*73-1$EG#>"8.LDGE,_W1QLPK#.>JXQWI?%DM\X>UDAB
M32+EH[.24.?.W2G8&4=,*Q7(/4$^G.=9^'&UBZ$^H+!#:,%DD;3[C]W>2C(\
MP #Y04)5N<D'&3@&@#1\"6&KZ?9F/49$%CY:"UMB_F26X P5+_Q ]1S\H..<
M9KJ:9%&L2*D:JB* JJHP !T %/H ***#TH ;(P12S$!5&22< "N/UR\?7!!8
MQA(M/NYMMK?K*LJ2R1KYF'C'#1$*W\7.TY X)L>*I+^7=:2Q0Q:1=,MFTVXF
M8/)PK@=-H8JI!Y.2>,<Y]EX;?6+Q;G48[>&R8+,RV%P3'=3 ,ID&!PK(Y!'4
MY'7&2 ;GAV/48KJ_2\N+BYM04\J6=54L^#OVX_@^[C/O16ZB+&BHBA548"@8
M 'I10 M<YK'B[3; 2Q1SQO=+((0KDI'O) (,F-O&<G&2,'TKHZX^?P_J#VG]
MCL;.32/M G6=W;SXU\S?LV;2K'/ ;<.#R"1R ,TW1KC[?+97-_-JFF*)59WN
M<-$9%P8W4#Y\ C;SP"<\X)ZG3+"VTVRBM+*(101C"J"3GU))Y)/4D\FG6-G:
MV-LMO8V\-M;K]V*% BK] .*L=* "BBB@ )Q7-ZOXNTVQ\R*.XB>Z640A9"4C
MWE@"/,Q@[<DD#)&#QQ71M7(2^'KY[./1V^QR:.MP)DG=V\]%#[]FS;M8]MVX
M<'D$]0 T[2)C>2V4][-J>F!98V=KG#1%UY1P!\V ?E] 3GG!/3:986VF645I
M8Q"*WB&%4<_B3U)/4D\DTZQL[6QMDM[&VAMK=/NQ0H$5?H!Q5B@ HHHH *YO
M5O%VFVI,,,\<MSYZVX5RR)N+A6^?&#MSDXR1@^E=)7&_\(Y?&RM-%F^Q3:/:
MS))%.[,9A&C96,IMVDX^4ONY'44 )I6BW'VJ:QO+^?5=-2.6 S/<X="X&Y)%
M ^9@" IXP.V>3U6FV5OIUC#:642Q6\2[44=O\3ZGO3K&TM[*U2VLH(;>WC&$
MBA0(JCT ' J>@ HHHH *YG5?%NFPG[/;SQRW,DRVRART:9+!6(<C!VYYVYKI
M6KCU\.7KV=AH]TMC-I%C+')'<,Q,S(A^6,Q[=N2/E+;N03QS0 NEZ1---<V%
M[>3:IIRQ26QG:YPX+$%D=0.7&0 P(P !@'.>IL;2"QM(K:TC6*")0J(HX I;
M.UM[*UCM[."*WMXQM2*) B*/0 <"IJ "BBB@ KF-3\6Z:-EK:7,<D]Q,MNI<
MM&GS'!97(PP'^SGD@<9KIG4.C*W1A@UQ_P#PCM]<6VGZ3J"V$^E6,B.DY),L
MB*,!&C*[1D':QW'()^49X %TO1I+@W5AJ%W-JFFB%[<7+7.&.7RRNJ@9<'C>
M#P   #FNKM+>&TMH[>VC6*&-=J(HP *2UMX+6WC@M88X((QM2.-0JJ/0 <"I
MJ "BBB@ -<QJ7BS32T=I:7*/<7$PMU9B8T&>"X<C# =/ESR5'&:Z29%EB='Y
M5E*GG'!KDO\ A';VYM].TO4DT^XTNQD5TG8EI954$!&C*[1D'#'<01G@9X $
MTS17NEN]/U&ZEU33/)>V%R;G#-\V65U4#YP>-X/0   YKK+6WBM;>."VC6*&
M-0J(HP%%%K;PVMO'!:PQPP1C:D<:A54>@ X J6@ HHHH *Y?4?%>FS&"RLKI
M&GO)OLRNQ:)0"#EU8C#=, KD%F49YKI+F%+FVE@ESY<J%&P<'!&#7*?\(_?7
MJZ=8:Q'IUSIU@^Y9CEI+A0A0*T97:N0WS?,0<=!G@ ;I>C27L-W8ZE<RZGIC
M0-:K=?:2"X#G<&5<?O 006![#&.176VT,=M!'#!&L<4:A411@*!V%);016T$
M<-O$D4,:A4CC4*J@=  . *EH **** $8A1D\"N8OO%&FW4MOI]E=J9KV4VX<
MDQ;1M8ET)'S?=P",C<5YYKH;ZW2[LY[:;<(YHVC;:<'!&#@URR^';V^.EVFN
MQ:==6.FDE9>6:Z'EM&%>,KM48;)^9@2HX'8 32]&:_M[FSU6YDU/3S$+=+H7
M)_>A'.<JN,2;@=S \X&,<@=;!#';PI% BQQ( J(HP% Z "B&&."%(H8TCB0!
M41!A5 Z #L*DH **** &NZHI9R%51DDG  KF+WQ-IVH26^FV-V/-O7,/F;FB
M*+M8[T)'S'C@C@GO70ZA:1WUC<6LQ81SQM&Q4X(!&.*YH:!>:C-IT&OP:9/9
M6 ;#KEVN@4*!7C9=JKR&(RWS*O3% #-*T4ZE:W%KJ\[ZE8;(XH[H7)Q,(WR"
M57&'R/F8'G'&!P.MAC2&)8XD5(T 5548"@= !1#$D,:QQ(J1H JJHP% Z "G
MT %%%% ".P12SD*JC)). !7+WOB73M0EM]-L;O$MZS1>;EHBB[2=Z;A\Q./E
M(X/K70:E:)?Z?<VDI98YXVC8H<$ C&17-#0+O4IM.B\0P:9<VE@K*'4%S=93
M;AHV7:@Z,1EN57IB@!-+T8ZE:SVVL3-J5CMB2*Z%R<3"-\@[5QAMR_,V?F[8
M' ZV.-(HU2)52-0%55&  .@%)%&D<:)&BHB@!548  [ 4^@ HHHH ;(ZQHS.
M0JJ,EB< #UKEK[Q'I^K20Z387I22^5T\X,87C7;G='N7YB?X<<<$YXQ70:K9
M)J.FW5G*S*D\;1EE.",CJ*Y_^PKO5KVS_P"$DM]+GMK1'3Y09/M6X ?,C+A!
MQG;EN<<\<@$>EZ)_:EG<P:S(VHV3^3Y5P+D[)EC8,I"#[IRH+')W'VX'71HL
M:*B*%11A548 'I21HL:*D:A548"@8 'I3J "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
>BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
